Document:

exv10w32

 

Exhibit 10.32

 

 

SHARE PURCHASE AGREEMENT

by and among

MCAFEE EUROPEAN HOLDINGS LIMITED,

MCAFEE, INC.

for purposes of Article XI (and the provisions of Article XII relating to the foregoing) only,

SAFEBOOT HOLDING B.V.,

THE SHAREHOLDERS OF SAFEBOOT HOLDING B.V.

set forth on Exhibit A in their capacities as such,

PAUL GROOTAERS

for purposes of Section7.14, Section 7.15 and Article XI (and the provisions of

Article XII relating to the foregoing) only,

STICHTING ADMINISTRATIEKANTOOR SAFEBOOT

and

SUMMIT PARTNERS III S.A.R.L., as Sellers’ Representative

Dated as of October 8, 2007

 

 

 

 

TABLE OF CONTENTS

	 	 	 	 	 
	 	 	Page
	ARTICLE I DEFINITIONS
	 	 	2	 
	 
	 	 	 	 
	1.1 Certain Defined Terms
	 	 	2	 
	1.2 Additional Defined Terms
	 	 	12	 
	1.3 Interpretations
	 	 	14	 
	 
	 	 	 	 
	ARTICLE II SHARE PURCHASE
	 	 	15	 
	 
	 	 	 	 
	2.1 The Share Purchase
	 	 	15	 
	2.2 The Purchase Price; Escrow Amounts
	 	 	15	 
	2.3 Purchase Price Adjustment with respect to Third-Party Expenses
	 	 	16	 
	2.4 Treatment of Company Options
	 	 	17	 
	2.5 Closing; Procedures for Payment of Purchase Price
	 	 	18	 
	2.6 Withholding Rights
	 	 	19	 
	2.7 Indebtedness
	 	 	20	 
	 
	 	 	 	 
	ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE COMPANYAND THE SELLERS WITH RESPECT TO THE COMPANY
	 	 	20	 
	 
	 	 	 	 
	3.1 Organization of the Company
	 	 	20	 
	3.2 Company Capital Structure
	 	 	20	 
	3.3 Subsidiaries
	 	 	21	 
	3.4 Authority and Enforceability; No Conflicts
	 	 	22	 
	3.5 Financial Statements; Internal Controls
	 	 	23	 
	3.6 No Undisclosed Liabilities
	 	 	23	 
	3.7 No Material Adverse Effect
	 	 	23	 
	3.8 Absence of Certain Developments
	 	 	23	 
	3.9 Tax Matters
	 	 	26	 
	3.10 Real Property
	 	 	29	 
	3.11 Assets
	 	 	29	 
	3.12 Intellectual Property
	 	 	30	 
	3.13 Material Contracts
	 	 	33	 
	3.14 Interested Party Transactions
	 	 	36	 
	3.15 Compliance With Laws; Permits
	 	 	36	 
	3.16 Litigation
	 	 	36	 
	3.17 Pensions
	 	 	37	 
	3.18 Employees
	 	 	38	 
	3.19 Insurance
	 	 	38	 
	3.20 Books and Records
	 	 	38	 
	3.21 Distributors, Resellers, Partners and Representatives
	 	 	38	 
	3.22 Export Control Laws
	 	 	39	 
	3.23 Corrupt Practices
	 	 	39	 

-i-

 

	 	 	 	 	 
	 	 	Page
	3.24 Brokers’ and Finders’ Fees; Third Party Expenses
	 	 	39	 
	 
	 	 	 	 
	ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE SELLERS
	 	 	40	 
	 
	 	 	 	 
	4.1 Authority
	 	 	40	 
	4.2 Non-Contravention
	 	 	40	 
	4.3 Necessary Approvals
	 	 	40	 
	4.4 Legal Ownership of Shares
	 	 	41	 
	4.5 Domicile of Sellers
	 	 	41	 
	 
	 	 	 	 
	ARTICLE V REPRESENTATIONS AND WARRANTIES OF BUYER
	 	 	41	 
	 
	 	 	 	 
	5.1 Organization and Qualification
	 	 	41	 
	5.2 Authority
	 	 	41	 
	5.3 No Breach
	 	 	42	 
	5.4 Litigation
	 	 	42	 
	5.5 Financial Means
	 	 	42	 
	 
	 	 	 	 
	ARTICLE VI CONDUCT PRIOR TO THE CLOSING DATE
	 	 	42	 
	 
	 	 	 	 
	6.1 Conduct of Business of the Company
	 	 	42	 
	6.2 Procedures for Requesting Buyer Consent
	 	 	45	 
	6.3 No Solicitation
	 	 	46	 
	6.4 Covenant Not To Transfer
	 	 	46	 
	 
	 	 	 	 
	ARTICLE VII ADDITIONAL AGREEMENTS
	 	 	47	 
	 
	 	 	 	 
	7.1 Access to Information
	 	 	47	 
	7.2 Public Disclosure
	 	 	47	 
	7.3 Employee Matters
	 	 	48	 
	7.4 Section 280G Payments
	 	 	48	 
	7.5 Regulatory Filings; Reasonable Efforts
	 	 	49	 
	7.6 Notification of Certain Matters
	 	 	50	 
	7.7 Consents
	 	 	50	 
	7.8 Further Assurances
	 	 	50	 
	7.9 New Employee Benefits
	 	 	51	 
	7.10 Tax Matters
	 	 	51	 
	7.11 Waiver of Certain Rights
	 	 	51	 
	7.12 Release of Claims
	 	 	51	 
	7.13 Confidentiality Obligations
	 	 	52	 
	7.14 Non-Competition; Non-Solicitation
	 	 	53	 
	7.15 Shareholders Agreement
	 	 	55	 
	 
	 	 	 	 
	ARTICLE VIII CONDITIONS TO CLOSING
	 	 	55	 
	 
	 	 	 	 
	8.1 Conditions to Obligations of Buyer and the Sellers
	 	 	55	 
	8.2 Additional Conditions to Obligations of Buyer
	 	 	55	 

-ii-

 

	 	 	 	 	 
	 	 	Page
	ARTICLE IX INDEMNIFICATION
	 	 	56	 
	 
	 	 	 	 
	9.1 Survival of Representation and Warranties
	 	 	56	 
	9.2 Indemnification by Sellers
	 	 	56	 
	9.3 Indemnification Limitations
	 	 	57	 
	9.4 Escrow; Claim Procedures
	 	 	58	 
	9.5 Exclusive Remedy
	 	 	60	 
	9.6 Sellers’ Representative
	 	 	61	 
	 
	 	 	 	 
	ARTICLE X TERMINATION
	 	 	63	 
	 
	 	 	 	 
	10.1 Termination
	 	 	63	 
	10.2 Effect of Termination
	 	 	64	 
	 
	 	 	 	 
	ARTICLE XI GUARANTEES
	 	 	64	 
	 
	 	 	 	 
	11.1 Liability for Payment of Purchase Price
	 	 	64	 
	11.2 Nature of Guarantee
	 	 	64	 
	11.3 Parent Representations and Warranties
	 	 	65	 
	11.4 Unconditional Guaranty
	 	 	65	 
	11.5 Nature of Guarantee
	 	 	65	 
	11.6 Mr. Paul Grootaers’s Representations and Warranties
	 	 	65	 
	 
	 	 	 	 
	ARTICLE XII GENERAL
	 	 	66	 
	 
	 	 	 	 
	12.1 Amendment
	 	 	66	 
	12.2 Waiver
	 	 	66	 
	12.3 Notices
	 	 	66	 
	12.4 No Third Party Beneficiaries
	 	 	69	 
	12.5 Entire Agreement
	 	 	69	 
	12.6 Governing Law
	 	 	69	 
	12.7 Consent to Jurisdiction
	 	 	69	 
	12.8 Assignment
	 	 	70	 
	12.9 Counterparts
	 	 	70	 
	12.10 Severability
	 	 	70	 
	12.11 Specific Performance
	 	 	70	 
	12.12 Waiver of Jury Trial
	 	 	70	 
	12.13 No Additional Representations
	 	 	70	 

Index of Exhibits

Exhibit A — List of Shareholders of the Company, Shareholdings and Distribution of the Adjusted Purchase Price

Exhibit B — Form of Escrow Agreement

Exhibit C-1 — List of Key Employees

Exhibit C-2 — Form of Key Employee Non-Competition and Non-Solicitation Agreement

Exhibit D — Disclosure Schedule

-iii-

 

Exhibit E — Form of Deed of Transfer

Exhibit F — Form of Assumption Agreement

Exhibit G — Form of Termination Agreement

Exhibit H — Form of Stichting Resolutions

Index of Schedules

Schedule 2.3 — Specified Third Party Expenses

Schedule 7.3(b) — List of Company Foreign Employees

Schedule 9.1(a)(iii) — Specified Matters

-iv-

 

SHARE PURCHASE AGREEMENT

     THIS SHARE PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of October 8,
2007 by and among McAfee European Holdings Limited, a company organized under the laws of the
Republic of Malta, and an indirect wholly owned subsidiary of Parent (“Buyer”), McAfee, Inc., a
Delaware corporation (for purposes of Article XI, and the provisions of Article XII relating
thereto, only) (“Parent”), Safeboot Holding B.V., a private limited company with limited liability
organized under the laws of The Netherlands having its registered office at Nieuwegein, The
Netherlands (the “Company”), each of the individuals and entities listed on Exhibit A
hereof, in their capacity as a holder of Company Capital Stock and/or Company Options and/or
Depositary Receipts (each as defined herein) as identified as such on Exhibit A (each a
"Seller” and collectively, the “Sellers”), Stichting Administratiekantoor Safeboot, a foundation
organized under the laws of The Netherlands having its registered office at Breukelen, The
Netherlands, registered with trade number 30199120 (the “Stichting”), Summit Partners III S.a.r.l.
as the Sellers’ Representative (the “Sellers’ Representative”), and Mr. Paul Grootaers (for
purposes of Section 7.14, Section 7.15 and Article XI, and the provisions of Article XII relating
thereto, only) (each, a “Party” and collectively, the “Parties”).

RECITALS

     A. Each Seller owns all of the issued and outstanding shares of Company Capital Stock (the
"Shares”), as well as that number of Company Options and/or Depositary Receipts as is set forth
opposite such Seller’s name on Exhibit A.

     B. Buyer desires to purchase from the Sellers, and the Sellers desire to sell to Buyer, the
Shares, all upon the terms and subject to the conditions set forth in this Agreement (the “Share
Purchase”).

     C. In connection with the Share Purchase, and as an inducement for the Sellers to enter into
this Agreement, Parent, which indirectly holds and controls 100% of the outstanding share capital
of Buyer, has agreed to guarantee, as a primary obligor, any and all obligations of Buyer
hereunder.

     D. As an integral part of the Share Purchase, the Stichting, being one of the Sellers pursuant
to this Agreement, has agreed to sell to Buyer the Shares set forth opposite its name on
Exhibit A and has agreed, in connection therewith and in fulfillment of its obligations
under the Stichting Trust Documents (as defined herein), to deliver the proceeds of the sale of
such Shares, less any amounts to be placed in escrow as contemplated hereunder, to the holders of
the Depositary Receipts issued by the Stichting and representing such Shares.

     E. In connection with the Share Purchase, Parent has agreed to assume the Company Options and
the Stichting has agreed to take all actions necessary or appropriate, including those specific
actions set out herein, to cause the assumption of any vested and unvested Company Options
outstanding as of the Closing Date in accordance with the terms and conditions set forth herein.

- 1 -

 

     E. Concurrently with the execution and delivery of this Agreement, and as a material
inducement to Buyer to enter into this Agreement, the current employees of the Company set forth on
Exhibit C-1 are entering into and executing, as applicable, employment offer letters (and, in the
case of Mr. Gerhard Watzinger, an employment agreement) and non-competition and non-solicitation
agreements in the forms attached as Exhibit C-2 (collectively, the “Key Employee Agreements”) with
Buyer, each of which shall become effective as of the closing.

     NOW, THEREFORE, in consideration of the foregoing premises, and the mutual covenants,
agreements, representations and warranties set forth herein, and for other good and valuable
consideration, the receipt and legal sufficiency of which are hereby acknowledged and accepted, and
intending to be legally bound hereby, the Parties hereto hereby agree as follows:

ARTICLE I

DEFINITIONS

     1.1 Certain Defined Terms. For all purposes of and under this Agreement, the following
capitalized terms shall have the following respective meanings:

     “Action” means any action, claim, proceeding, suit, hearing, litigation, audit or
investigation (whether civil, criminal, administrative, judicial or investigative), or any appeal
therefrom.

     “Adjusted Purchase Price” means the Purchase Price minus Seventy-Six Million, Four-Hundred and
Eighty-One Thousand, Two-Hundred and Thirty-Six ($76,481,236) minus, on a dollar-for-dollar basis,
the amount of all Third Party Expenses pursuant to the definition thereof as set forth in the Third
Party Expenses Statement delivered pursuant to Section 2.3 (converted into U.S. dollars by
multiplying such amount by the Currency Conversion Rate).

     “Affiliate” means with respect to any Person, any other Person, whether or not existing on the
date hereof, controlling, controlled by or under common control with such first Person. The term
“control” (including, with correlative meaning, the terms “controlled by” and “under common control
with”), as used with respect to any Person, means the possession, directly or indirectly, of the
power to direct or cause the direction of the management and policies of such Person, whether
through the ownership of voting securities, by contract or otherwise.

     “Aggregate CBB Option Exercise Price” shall mean the aggregate dollar amount obtained by
multiplying (i) the Currency Conversion Rate by (ii) the sum of the aggregate exercise prices in
Euros of all in-the-money CBB Options outstanding as of the close of business in Amsterdam, The
Netherlands on the Option Exercise Cutoff Date, plus the sum of the aggregate exercise prices in
Euros of all vested CBB Options exercised between the date of this Agreement and the close of
business in Amsterdam, The Netherlands on the Option Exercise Cutoff Date.

     “Aggregate Company Option Exercise Price” shall mean the aggregate dollar amount obtained by
multiplying (i) the Currency Conversion Rate by (ii) the sum of the aggregate exercise
prices in Euros of all in-the-money Company Options (other than the CBB Options) outstanding
as of the close of business in Amsterdam, The Netherlands on the Option Exercise Cutoff Date.

- 2 -

 

     “Aggregate Participation Consideration” shall mean the aggregate amount of Adjusted Purchase
Price remaining after subtracting the Aggregate Preference Amount from the Adjusted Purchase Price.

     “Aggregate Preference Amount” shall mean an aggregate amount of cash in U.S. dollars equal to
the product obtained by multiplying the Per Share Preference (converted into U.S. dollars by
multiplying such amount by the Currency Conversion Rate) by the Total Outstanding Company
Preference Shares.

     “Ancillary Agreements” shall mean the Confidentiality Agreement, the Escrow Agreement, and the
certificates and instruments delivered by the Company as contemplated by this Agreement.

     “Business Day” shall mean each day that is not a Saturday, Sunday or other day on which Buyer
is closed for business or banking institutions located in San Francisco, California, Amsterdam, The
Netherlands or London, United Kingdom are authorized or obligated by applicable Law or executive
order to close.

     “CBB” shall mean Control Break Beheer B.V., a company organized under the laws of The
Netherlands with its registered office at Breukelen, The Netherlands.

     “CBB Options” shall mean the 1,023,828 Company Options each of which, when exercised, will
entitle the holder thereof to a Depository Receipt from the Stichting for which the Stichting has a
right to acquire a CBB Share underlying such Depository Receipt.

     “CBB Shares” shall mean the 1,023,828 Company Ordinary Shares held by CBB which are
transferable to the Stichting upon the exercise of the CBB Options, but only to the extent that
such CBB Shares do not become Exercised Shares.

     “Civil Law Notary” shall mean civil law notary J.H.J Preller or another civil law notary of
NautaDutilh, or any of their deputies.

     “Code” shall mean the Internal Revenue Code of 1986, as amended.

     “Company Capital Stock” shall mean the Company Ordinary Shares, the Company Preference Shares
and any other shares of capital stock of the Company.

     “Company Employee Plan” shall mean any plan, program, policy, practice, contract, agreement or
other arrangement providing for compensation, severance, termination pay, deferred compensation,
performance awards, stock or stock-related awards, welfare benefits, fringe benefits or other
employee benefits or remuneration of any kind, whether written, unwritten or otherwise, funded or
unfunded, including without limitation, each “employee benefit plan,” within the meaning of Section
3(3) of ERISA, which is or has been maintained, contributed to, or required to be
contributed to, by the Company or any ERISA Affiliate for the benefit of any Company Employee,
or with respect to which the Company or any ERISA Affiliate has or may have any liability or
obligation and any International Employee Plan.

- 3 -

 

     “Company Employee” shall mean any current or former Employee of the Company and its
Subsidiaries or any ERISA Affiliate and “Company Employees” shall mean each Company Employee.

     “Company Intellectual Property” shall mean any and all Technology and Intellectual Property
Rights that are, or are purported to be, owned by or exclusively licensed to the Company.

     “Company Material Adverse Effect” shall mean any change, event, circumstance, effect or
development that, individually or taken together with any other change, event, circumstance, effect
or development (any such item, an “Effect”), is or is reasonably expected to be or become
materially adverse to the financial condition, assets (including intangible assets), Liabilities,
business or results of operations of the Company and its Subsidiaries, taken as a whole; provided,
however, that none of the following shall be taken into account in determining whether a “Company
Material Adverse Effect” has occurred or is reasonably expected to occur: (A) any Effect directly
attributable to the announcement or pendency of the transactions contemplated by this Agreement;
(B) any Effect arising from or related to conditions generally affecting the industry in which such
entity or its Subsidiaries operate or the global securities markets or the world economy; (C) any
Effect resulting from or relating to the taking of any action required by, or consented to in
writing by Buyer under, this Agreement; (D) any Effect arising from or relating to any change in
IFRS or any change in applicable Laws or the interpretation thereof, in each case, applicable to
such entity or its Subsidiaries; or (E) any Effect arising from or relating to the commencement,
continuation or escalation of a war, material armed hostilities or other material international or
national calamity or act of terrorism; provided, further that, (x) any such Effect described in the
foregoing clauses (B) and (E) does not affect such entity or its Subsidiaries disproportionately,
in any material respect, as compared to such entity’s competitors and (y) any unexpected Effect
having a positive effect on the Company and/or any of its Subsidiaries shall be taken into account
as a mitigating factor to the extent relevant in determining whether or not there has been or will
be a Company Material Adverse Effect.

     “Company Option” shall mean any issued and outstanding option (including commitments to grant
options, but excluding Company Preference Shares), whether or not vested, to purchase or otherwise
acquire a Depository Receipt from the Stichting for which the Stichting is obligated under the
Stichting Trust Documents to acquire a share of Company Capital Stock underlying such Depository
Receipt, and shall, for the avoidance of doubt, include the CBB Options.

     “Company Option Plan” shall mean the Safeboot Option Plan 2006.

     “Company Ordinary Shares” shall mean ordinary shares, nominal value €0.01 per share, of the
Company.

     “Company Preference Shares” shall mean the Series A preference shares, nominal value €0.10 per
share, of the Company.

     “Company Products” shall mean all products and services developed (including products and
services for which development is substantially completed), manufactured, made commercially

- 4 -

 

available, marketed, distributed, sold, imported for resale or licensed out by or on behalf of the
Company or any of its Subsidiaries (and their predecessor Entities) since its inception, and all
products and services which the Company or any of its Subsidiaries intends to manufacture, make
commercially available, market, distribute, sell, import for resale, or license out within twelve
(12) months after the date hereof.

     “Company Share Plans” shall mean the Safeboot Share Plan 2004 and the Company Option Plan.

     “Consolidated Group” shall mean an affiliated, consolidated, combined or unitary group for Tax
purposes (including any arrangement for group or consortium relief or similar arrangement).

     “Contract” shall mean any mortgage, indenture, lease, contract, covenant, plan, insurance
policy or other contract, agreement, instrument, arrangement, understanding or commitment, permit,
concession, franchise or license.

     “Conversion Ratio” shall mean the quotient obtained by dividing (i) the Purchase Price Per
Ordinary Share by (ii) the Parent Stock Price.

     “Credit Facility” shall mean that certain €60 million term and revolving credit facility with
NIBC Bank N.V. with the Company as the borrower thereunder, and all Contracts and other
documentation relating thereto.

     “Currency Conversion Rate” shall mean the exchange rate for the conversion of Euros into
United States dollars as reported in The Wall Street Journal on the Option Exercise Cutoff Date.

     “Deed of Transfer” shall mean the notarial deed of transfer of the Shares in the form set
forth as Exhibit E hereto.

     “Depository Receipt” shall mean a depository receipt (“een certificaat van een aandeel”)
issued by the Stichting related to and corresponding with one (1) Company Ordinary Share.

     “Distribution Amount” means the Escrow Amount and any net earnings thereon less (i) any
amounts paid to the Indemnified Parties pursuant to Article IX from the Escrow Amount and (ii) the
Holdback Amount.

     “Dutch GAAP” shall mean generally accepted accounting principles as laid down in Book 2 of the
Dutch Civil Code as consistently applied by the Company in 2004 and 2005 (excluding IFRS).

     “Employee” shall mean an employee, consultant, independent contractor or director.

     “Employee Agreement” shall mean each management, employment, severance, separation,
settlement, consulting, contractor, relocation, repatriation, expatriation, loan, visa, work permit
or other agreement, or contract (including, any offer letter or any other agreement providing for

- 5 -

 

compensation or benefits) between the Company or any ERISA Affiliate and any Company Employee.

     “Entity” shall mean any Person that is not a natural person.

     “ERISA” shall mean the U.S. Employee Retirement Income Security Act of 1974, as amended.

     “ERISA Affiliate” shall mean any other Person under common control with the Company within the
meaning of Section 414(b), (c), (m) or (o) of the Code, and the regulations issued thereunder.

     “Escrow Amount” shall mean an amount equal to Forty Three Million, Seven Hundred and Fifty
Thousand Dollars ($43,750,000).

     “Escrow Distribution” shall mean, with respect to any Seller, the Distribution Amount
multiplied by such Seller’s Pro Rata Portion.

     “Escrow Release Date” shall mean the date of the eighteen (18) month anniversary of the
Closing Date.

     “Exercised Share” shall mean any Company Ordinary Share held by the Stichting as a result of
the exercise, between the date of this Agreement and the close of business in Amsterdam, The
Netherlands on the Option Exercise Cutoff Date, of a CBB Option.

     “Export Control Laws” shall mean any U.S. or applicable non-U.S. law governing imports,
exports, economic sanctions or embargoes, or compliance with unsanctioned foreign boycotts.

     “Governing Documents” shall mean the articles of association, charter, organizational and
other documents by which any Person (other than an individual) establishes its legal existence or
which govern its internal affairs, the rights, preferences, and privileges of its shares, stock,
quotas or other forms of equity interest, or its authority to issue any such shares, stock, quotas
or other forms of equity interest, and shall include: (i) in respect of a corporation, its
certificate or articles of incorporation or memorandum or articles of association and/or its
bylaws; and (ii) in respect of a partnership, its certificate of partnership and its partnership
agreement, in each case, as amended to the date hereof.

     “Governmental Entity” shall mean any supranational, national, state, municipal, local or
foreign government, any court, arbitrator, administrative agency, commission or other governmental
official, authority or instrumentality, in each case whether domestic or foreign, any stock
exchange or similar self-regulatory organization or any quasi-governmental or private body
exercising any regulatory, Taxing or other governmental or quasi-governmental authority.

     “HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.

- 6 -

 

     “IFRS” shall mean International Financial Reporting Standards as adopted by the European
Union, consistently applied by the Company.

     “Indebtedness” means with respect to any Person (a) all obligations of such Person for
borrowed money, whether current or funded, secured or unsecured, (b) all obligations of such Person
for the deferred purchase price of any property or services (other than trade accounts payable
arising in the ordinary course of the business of such Person), (c) all obligations of such Person
created or arising under any conditional sale or other title retention agreement with respect to
property acquired by such Person (even though the rights and remedies of the seller or lender under
such agreement in the event of a default may be limited to repossession or sale of such property),
(d) all obligations of such Person secured by a purchase money mortgage or other lien to secure all
or part of the purchase price of property subject to such mortgage or lien, (e) all obligations
under leases which shall have been or should be, in accordance with IFRS or other generally
accepted accounting principles as applicable to such Person, recorded as capital leases in respect
of which such Person is liable as lessee, (f) any obligation of such Person in respect of bankers’
acceptances, (g) any obligations secured by Liens on property acquired by such Person, whether or
not such obligations were assumed by such Person at the time of acquisition of such property, (h)
all obligations of a type referred to in clauses (a), (b), (c), (d), (e), (f), (g) or (h) above
which is directly or indirectly guaranteed by such Person or which it has agreed (contingently or
otherwise) to purchase or otherwise acquire or in respect of which it has otherwise assured a
credit against loss, and (i) any refinancings of any of the foregoing obligations.

     “Intellectual Property Rights” shall mean any and all legal rights in any and all
jurisdictions throughout the world, whether or not filed, perfected, registered or recorded, in or
associated with any of the following: (a) United States and foreign patents and applications
therefor, and including any patent or application that is a provisional application, reissue,
re-examination, renewal, extension or continuation of a patent or patent application; (b) know-how,
trade secret rights and all other rights in or to confidential business or technical information;
(c) copyrights, copyright registrations and applications therefor and all other rights
corresponding thereto throughout the world; (d) trademarks, service marks, logos, trade dress
rights and similar designation of origin and rights therein, registrations and applications for
registration therefor; (e) industrial design rights and any registrations and applications
therefor; (f) URLs, WWW address, and domain names; (g) databases and data collections (including
knowledge databases, customer lists and customer databases); and (h) any similar, corresponding or
equivalent rights to any of the foregoing anywhere in the world.

     “International Employee Plan” shall mean each Company Employee Plan or Employee Agreement that
has been adopted or maintained by the Company or any ERISA Affiliate, whether formally or
informally or with respect to which the Company or any ERISA Affiliate will or may have any
liability with respect to employees who perform services outside the United States.

     “IRS” shall mean the United States Internal Revenue Service.

- 7 -

 

     “Law” shall mean any law, statute, rule, regulation, ordinance, directive, decree, code,
award, Order, or other pronouncement having the effect of law of any country or state, or of any
Governmental Entity.

     “Liability” shall mean any debt, liability, commitment or obligation of any kind, character or
nature whatsoever, whether known or unknown, secured or unsecured, fixed, absolute, contingent or
otherwise, and whether due or to become due.

     “Liens” shall mean any lien, pledge, charge, claim, mortgage, security interest or other
encumbrance of any sort.

     “Made Available” shall mean that the Company has posted such materials, on or before the third
(3rd) Business Day prior to the date of this Agreement, to the virtual data room managed
by the Company at https://datasite.merrillcorp.com or has actually delivered such documents to
Buyer or its Representatives.

     “Open Source Material” shall mean any open source, public source or freeware Software, or any
modification or derivative thereof, including any version of any Software licensed pursuant to any
GNU General Public License (GPL), GNU Lesser General Public License (LGPL), Mozilla Public License
(MPL), BSD licenses, the Artistic License, the Netscape Public License, the Sun Community Source
License (SCSL), the Sun Industry Standards License (SISL), the Apache License or other Software
that is licensed pursuant to a license that purports to require the distribution of, or access to,
Source Code, or purports to restrict the licensee’s ability to charge for distribution of, or to
use of such Software for commercial purposes, or that purports to impose any notice requirements
with respect to the distribution or licensing of such Software or derivatives thereof.

     “Option Exercise Cutoff Date” shall mean the date that is three (3) Business Days prior to the
Closing Date.

     “Order” shall mean any writ, judgment, decree, award, ruling, injunction or similar order of
any Governmental Entity, in each case whether preliminary or final.

     “Parent Common Stock” shall mean shares of common stock, par value $0.01 per share, of Parent.

     “Parent Stock Price” shall mean the weighted average closing sale price for a share of Parent
Common Stock as quoted on the New York Stock Exchange for the ten (10) trading day period ending on
the trading day prior to the Closing Date.

     “Pension Plan” shall mean each Company Employee Plan that is an “employee pension benefit
plan,” within the meaning of Section 3(2) of ERISA, or any managers’ insurance policies, pension
funds, further education funds and provident funds maintained by the Company.

     “Permits” shall mean all licenses, certifications, accreditations, permits, franchises, or
filings with any governmental or other self regulatory organization or regulatory authority,
whether foreign,

- 8 -

 

federal, state or local, or any other Person, necessary for the operation of the Company’s
business as currently conducted.

     “Permitted Liens” shall mean (i) liens for Taxes and other similar governmental charges and
assessments which are not yet due and payable, or which are being contested in good faith and for
which adequate reserves have been established, (ii) liens of landlords and liens of carriers,
warehousemen, mechanics and materialmen and other like liens arising in the ordinary course of
business consistent with past practice for sums not yet due and payable, (iii) security given in
the ordinary course of business consistent with past practice to any public utility, Governmental
Entity or other statutory or public authority having jurisdiction over the Company or any of its
Subsidiaries, and (iv) zoning, entitlement, building and other land use regulations imposed by
Governmental Entities having jurisdiction over the Leased Real Property which are not violated by
the current use and operation of the Leased Real Property.

     “Per Share Preference” shall mean an amount of cash equal to 8.00% per annum of Twenty-Eight
Million, Eight-Hundred and Eight Thousand Euros (€28,808,000) from and including June 16, 2007
through the Closing Date, as set out in the Articles of Association of the Company as they exist as
of the date hereof.

     “Person” shall mean any individual, corporation (including any non-profit corporation),
general partnership, limited partnership, limited liability partnership, joint venture, estate,
trust, company (including any limited liability company or joint stock company), firm or other
enterprise, association, organization, entity or Governmental Entity.

     “Post-Closing Tax Period” shall mean a Tax period that commences after the Closing Date.

     “Pre- to Post-Closing Tax Period” shall mean a Tax period commencing prior to the Closing Date
but ending thereafter.

     “Pro Rata Portion” shall mean, with respect to each Seller, an amount equal to the quotient
obtained by dividing (x) the shares of Company Capital Stock held by such Seller as of the Closing
Date, by (y) the total number of shares of Company Capital Stock outstanding as of the Closing
Date.

     “Purchase Price Per CBB Share” shall mean the Aggregate CBB Option Exercise Price divided by
the number of CBB Shares issued and outstanding as of the close of business in Amsterdam, The
Netherlands on the Option Exercise Cutoff Date.

     “Purchase Price Per Exercised Share” shall mean an amount of cash in U.S. dollars equal to the
Purchase Price Per Ordinary Share minus the result of (x) the aggregate exercise price of all CBB
Options exercised between the date of this Agreement and the close of business in Amsterdam, The
Netherlands on the Option Exercise Cutoff Date divided by (y) the number of Exercised Shares.

     “Purchase Price” shall mean Three-Hundred and Fifty Million Dollars ($350,000,000).

- 9 -

 

     “Purchase Price Per Ordinary Share” shall mean an amount of cash in U.S. dollars equal to the
quotient obtained by dividing (x) the sum of (i) the Aggregate Participation Consideration plus
(ii) the Aggregate Company Option Exercise Price by (y) the Total As-Converted Outstanding Shares.

     “Purchase Price Per Preference Share” shall mean an amount of cash equal to the sum of (i) the
Per Share Preference (as converted to U.S. dollars by multiplying such amount by the Currency
Conversion Rate) plus (ii) the Purchase Price Per Ordinary Share.

     “Representatives” shall mean with respect to any Person, its Affiliates and the stockholders,
employees, officers, directors, investment bankers, attorneys, accountants, agents and authorized
representatives of such Person or its Affiliates.

     “Seller Paid M&A Expenses” shall mean those expenses referenced in clauses (i)(A) and (ii)(A)
of the definition of “Third Party Expenses” that have been fully paid prior to the Closing Date by
the Sellers, it being understood and agreed that all Contracts contemplating such expenses that are
obligations of the Company or any of its Subsidiaries shall (unless otherwise directed in writing
by Buyer) be amended prior to the Closing Date such that all obligations thereunder are assumed by
the Sellers (with no further obligation on the Company or any of its Subsidiaries).

     “Shareholders Agreement” shall mean the Shareholders Agreement dated as of October 31, 2005 by
and among the Company, Summit Partners III S.a.r.l, CBB, Mr. Gerhard Watzinger, the Stichting and
Mr. Paul Grootaers.

     “Stichting Trust Documents” shall mean the trust conditions (“administratievoorwaarden”) and
the Articles of Association (“statuten”) of the Stichting, in each case, as amended on October 7,
2007.

     “Subsidiary” shall mean any Person, whether or not existing on the date hereof, in which the
Company or Buyer, as the context requires, directly or indirectly through subsidiaries or
otherwise, beneficially owns at least fifty percent (50%) of either the equity interest, or voting
power of or in such Person.

     “Tax,” “Taxation,” or, collectively, “Taxes” shall mean (i) any and all taxes, assessments and
other charges, duties, impositions, installments and Liabilities imposed by or on behalf of any
Governmental Entity, including taxes based upon or measured by gross receipts, income, profits,
sales, use and occupation, capital and value added (“VAT”), goods and services, ad valorem,
transfer, franchise, withholding, payroll, recapture, employment, excise and property taxes as well
as public imposts, fees and social security charges (including health, unemployment, workers’
compensation and pension insurance), together with all interest, penalties and additions imposed
with respect to such amounts, (ii) any Liability for the payment of any amounts of the type
described in clause (i) above as a result of being or ceasing to be a member of a Consolidated
Group for any period, and (iii) any Liability for the payment of any amounts of the type described
in clauses (i) or (ii) above as a result of any express or implied obligation to indemnify any
other person or as a result

- 10 -

 

of any obligation under any agreement or arrangement with any other person with respect to
such amounts and including any Liability for taxes of a predecessor or transferor.

     “Tax Authority” shall mean any Governmental Authority endowed with the authority to enforce
obligations in connection with Tax.

     “Tax Return” shall mean returns, estimates, amendments, information statements, elections,
forms, transfer pricing or other technical studies and reports, and any attachments, appendices or
addenda thereto relating to any and all Taxes, and including any workpapers or other documents upon
which any of the foregoing are based.

     “Technology” shall mean any or all of the following in any form or media: (i) works of
authorship, including computer programs in any form, including but not limited to, source code and
object code, whether embodied in software, firmware or otherwise, development tools, documentation,
designs, files, records, data and all media on which any of the foregoing is recorded, all mask
works; (ii) inventions (whether or not patentable), improvements, and technology; (iii) proprietary
and confidential information, trade secrets and know how; (iv) databases, data compilations and
collections, customer lists and technical data; (v) domain names, Web addresses and sites; and
(vii) tools, methods and processes.

     “Territories” shall mean all of the countries in which the Company and its Subsidiaries sell
products or provide services as of the Closing Date.

     “Third Party Expenses” shall mean (i) any fees, expenses and disbursements of legal,
accounting and financial advisors incurred or agreed to be incurred by the Company or any of its
Subsidiaries (or required by any officer, director or shareholder of such Person to be incurred by
such Person) in connection with the negotiation and effectuation of (A) the terms and conditions of
this Agreement and the transactions contemplated hereby (including without limitation the financial
advisory fee set forth on Schedule 2.3 hereto that is payable by the Company), and (B) the
proposed initial public offering of the Company, (ii) any other third party fees and expenses
incurred or agreed to be incurred by the Company or any of its Subsidiaries (or required by any
officer, director or shareholder of such Person to be incurred by such Person) in connection with
the negotiation and effectuation of (A) the terms and conditions of this Agreement and the
transactions contemplated hereby and (B) the proposed initial public offering of the Company,
including in each case any consulting fees and expenses, (iii) in the case of the Company, any
stay-bonus, success bonus, transaction completion bonus or other similar payment made or required
to made to the employees of the Company or any of its Subsidiaries on or after the Closing as a
result of the transactions contemplated hereby, which payment is made pursuant to an agreement
entered into by the Company or any of its Subsidiaries prior to the Closing unless agreed to after
the date hereof in writing by Buyer, and (iv) any penalties or fees resulting from the prepayment
or repayment of the Credit Facility; provided that, for the sake of clarity, all Third Party
Expenses referenced in clauses (i) through (iv) (other than Seller Paid M&A Expenses), whether paid
prior to or after the date hereof, or unpaid or accrued as of the Closing Date shall constitute
Third Party Expenses for purposes of this Agreement, except that Seller Paid M&A Expenses will
still be required to be disclosed on the Third Party Expenses Statement.

-11-

 

     “Total As-Converted Outstanding Shares” shall mean the aggregate number of Company Ordinary
Shares issued and outstanding immediately prior to Closing plus the aggregate number of Company
Ordinary Shares issuable upon (i) the conversion of all Company Preference Shares and (ii) the
exercise of all in-the-money Company Options (whether vested or unvested) issued and outstanding as
of the close of business in Amsterdam, The Netherlands on the Option Exercise Cutoff Date.

     “Total Outstanding Company Preference Shares” shall mean the aggregate number of Company
Preference Shares issued and outstanding immediately prior to the Closing.

     “2005 Share Purchase Agreement” shall mean the share purchase and contribution agreement dated
as of October 31, 2005 by and among the Company, Summit Partners III S.a.r.l, Control Break Europe
B.V., and the Persons listed on the Schedule of Sellers thereto.

     1.2 Additional Defined Terms.  The following capitalized terms shall have the respective
meanings set forth in the Section of this Agreement set forth opposite each such respective term
below:

	 	 	 	 	 
	Term	 	Section	 
	Agreement
	 	Introduction
	Alternative Arrangements
	 	 	9.3	(a)
	Annual Financial Statements
	 	 	3.5	(a)
	Basket Amount
	 	 	9.3	(a)
	Books and Records
	 	 	3.20	 
	Buyer
	 	Introduction
	Buyer Obligations
	 	 	11.1	 
	CBB Obligations
	 	 	11.4	 
	Closing
	 	 	2.5	(a)
	Closing Cash Payment
	 	 	2.2	(a)
	Closing Date
	 	 	2.5	(a)
	Company
	 	Introduction
	Company Balance Sheet
	 	 	3.5	(a)
	Company Balance Sheet Date
	 	 	3.5	(a)
	Company Foreign Employee
	 	 	7.3	(b)
	Competing Transaction
	 	 	6.3	(a)
	Confidentiality Agreement
	 	 	7.13	(a)
	Confidential Information
	 	 	7.13	(c)
	Continuing Employees
	 	 	7.9	 
	Converted Options
	 	 	2.4	(a)
	Deferred Share Agreement
	 	 	2.4	(e)
	Deferred Shares
	 	 	2.4	(e)

-12-

 

	 	 	 	 	 
	Term	 	Section	 
	Delaware Court
	 	 	11.7	 
	Director Resignation Letter
	 	 	7.3	(a)
	Disclosure Schedule
	 	Article III
	Effective Time
	 	 	2.4	(a)
	Escrow Agent
	 	2.5(b)(ii)(2)
	Escrow Agreement
	 	2.5(b)(ii)(2)
	Escrow Fund
	 	2.5(b)(ii)(2)
	Excess Third Party Expenses
	 	 	2.3	 
	Financial Statements
	 	 	3.5	(a)
	Generally Available Commercial Code
	 	 	3.12	(b)
	Grootaers Guarantee
	 	 	11.4	 
	Holdback Amount
	 	 	9.4	(c)
	Identified Sellers
	 	 	7.14	(a)
	In-bound IP Agreements
	 	 	3.12	(b)
	Indemnified Party or Indemnified Parties
	 	 	9.2	(a)
	Leased Real Property
	 	 	3.10	 
	Leases
	 	 	3.10	 
	Loss or Losses
	 	 	9.2	 
	Material Contracts
	 	 	3.13	 
	OEM Partners
	 	 	3.21	(a)
	Out-bound IP Agreements
	 	 	3.12	(b)
	Owned Depository Receipts
	 	 	4.4	 
	Owned Options
	 	 	4.4	 
	Parent Guarantee
	 	 	11.1	 
	Party or Parties
	 	Introduction
	Payment Notice
	 	 	9.4	(b)
	Permitted Transfer
	 	 	6.4	 
	Pre-Closing Tax Period
	 	 	3.9	(c)
	Released Claims
	 	 	7.12	 
	Released Parties
	 	 	7.12	 
	Releasor Parties
	 	 	7.12	 
	Remaining Escrow Amount
	 	 	9.4	(c)
	Resolved Claim
	 	 	9.4	(c)
	Seller Approval
	 	 	4.3	(a)
	Seller or Sellers
	 	Introduction
	Sellers’ Representative
	 	Introduction
	Sellers’ Representative Expenses
	 	 	9.6	(c)
	Share Purchase
	 	Recitals

-13-

 

	 	 	 	 	 
	Term	 	Section	 
	Shares
	 	Recitals
	Specified Representations
	 	 	9.3	(a)
	Tax Ruling
	 	 	2.4	(d)
	Tax Rep Cutoff Date
	 	 	9.1	(a)
	Third Party Claim Notice
	 	 	9.4	(d)
	Third Party Expenses Statement
	 	 	2.3	 
	Top Distributors
	 	 	3.21	(a)
	Transfer
	 	 	6.4	 
	Transfer Taxes
	 	 	7.10	 
	Unaudited Financial Statements
	 	 	3.5	(a)
	Withholding Certificate
	 	 	2.6	 

     1.3 Interpretations. 

          (a) When a reference is made in this Agreement to an Exhibit or a Schedule, such reference
shall be to an Exhibit or a Schedule to this Agreement unless otherwise indicated.

          (b) When a reference is made in this Agreement to an Article or a Section, such reference
shall be to an Article or a Section of this Agreement unless otherwise indicated.

          (c) The words “include,” “includes” and “including” when used herein shall be deemed in each
case to be followed by the words “without limitation.”

          (d) The word “knowledge” when used herein (i) with respect to the Company or its Subsidiaries
shall be deemed in each case to mean the actual knowledge of any director of the Company or its
Subsidiaries and the following officers of the Company: Mr. Gerhard Watzinger, Mr. Piet Weijers,
Mr. Simon Hunt, Mr. Marco Versteijne and Mr. Paul Parke; and (ii) with respect to any Seller shall
mean (A) in the case of Summit Partners III S.a.r.l, the actual knowledge of Mr. Scott Collins and
Mr. Sotiris Lyritzis, (B) in the case of CBB, the actual knowledge of Mr. Paul Grootaers, and (C)
in the case of Mr. Gerhard Watzinger, his actual knowledge.

          (e) The headings set forth in this Agreement are for reference purposes only and shall not
affect in any way the meaning or interpretation of this Agreement.

          (f) Unless otherwise specifically provided or the context otherwise requires, all references
in this Agreement to the Company shall mean and refer to the Company and its direct and indirect
Subsidiaries. All references in this Agreement to the Subsidiaries of a Person shall be deemed to
include all direct and indirect Subsidiaries of such Person.

          (g) Any dollar or Euro thresholds set forth herein shall not be used as a benchmark for
determination of what is or is not “material” or a “Material Adverse Effect” under this Agreement.

-14-

 

          (h) Unless otherwise specifically provided, all references in this Agreement to “Dollars” or
“$” shall mean means United States Dollars; and all references to “Euros” or “€”shall refer to
the common currency of the European Union.

          (i) As used in this Agreement, the singular or plural number shall be deemed to include the
other whenever the context so requires. Article, Section, clause and Schedule references contained
in this Agreement are references to Articles, Sections, clauses and Schedules in or to this
Agreement, unless otherwise specified.

          (j) The Parties hereto agree that they have been represented by legal counsel during the
negotiation and execution of this Agreement and, therefore, waive the application of any law,
regulation, holding or rule of construction providing that ambiguities in an agreement or other
document shall be construed against the party drafting such agreement or document.

ARTICLE II

SHARE PURCHASE

     2.1 The Share Purchase.  At the Closing and subject to and upon the terms and conditions of
this Agreement, Buyer shall purchase for the consideration specified herein from each Seller and
each Seller shall sell, convey, transfer, assign and deliver to Buyer, free and clear of all Liens,
encumbrances or other defects of title, all of the issued and outstanding Shares held by such
Seller as set forth opposite such Seller’s name on Exhibit A hereto, as updated pursuant to
the next sentence. No later than three (3) Business Days prior to the Closing Date, the Company
shall deliver to Buyer a revised Exhibit A, updated to reflect all issued and outstanding
Shares held by the Sellers, which shall constitute all of the issued and outstanding Shares as of
the Closing Date, the name in which such Shares are held by such Sellers, and such other
information with respect thereto that is currently set forth on such Exhibit A, as well as
to reflect any adjustments to the Adjusted Purchase Price required pursuant to Section 2.3 hereto
for Third Party Expenses; such revised Exhibit A shall be certified as to its accuracy as
of the Closing Date by the Company’s Chief Executive Officer or Chief Financial Officer.

     2.2 The Purchase Price; Escrow Amounts.  Upon the terms and conditions set forth in this
Agreement, at Closing Buyer shall pay the Adjusted Purchase Price to the Sellers or deposit such
portions of the Adjusted Purchase Price in escrow as follows; provided, that, it is understood and
agreed that the formulas contained in this Agreement and the amounts to be paid to each Seller as
described in this Section 2.2 and as set forth in Exhibit A have been reviewed and
consented to by each Seller and that Buyer shall have no liability for any errors and omissions in
such formulas or Exhibit A to any Seller, or for any payment of the Adjusted Purchase Price
to any Seller after delivery of the Closing Cash Payment to the Civil Law Notary:

          (a) Buyer shall pay to each Seller an aggregate amount in cash in U.S. dollars equal to (i)
the sum of (A) the number of Company Ordinary Shares (other than the CBB Shares or Exercised
Shares) owned by such Seller as reflected in Exhibit A as properly updated in accordance
with this Agreement multiplied by the Purchase Price Per Ordinary Share, plus (B) the number of
Company Preference Shares owned by such Seller as reflected in Exhibit A as properly
updated in

-15-

 

accordance with this Agreement multiplied by the Purchase Price Per Preference Share,
plus (C) the
number of Exercised Shares owned by such Seller as reflected in Exhibit A as properly
updated in accordance with this Agreement, multiplied by the Purchase Price Per Exercised Share,
plus (D) the number of CBB Shares owned by such Seller as reflected in Exhibit A as
properly updated in accordance with this Agreement multiplied by the Purchase Price Per CBB Share,
minus (ii) such Seller’s Pro Rata Portion multiplied by the Escrow Amount (with amounts greater
than or equal to $0.005 rounded up). Such cash amount in the aggregate shall be referred to herein
as the “Closing Cash Payment”.

          (b) Buyer will deposit the Escrow Amount with the Escrow Agent pursuant to the Escrow
Agreement in immediately available U.S. dollar funds by wire transfer.

          (c) For the sake of clarity, Buyer will transfer the Closing Cash Payment to the bank account
in the name of Kwaliteitsrekening Notarissen Rotterdam NautaDutilh N.V. with ABN AMRO Bank N.V.
(404425909), IBAN: NL62ABNA0404425909, BIC: ABNANL2A, with reference to file number 80047190. The
Sellers hereby acknowledge that The Civil Law Notary is hereby instructed by the Sellers
immediately after the Deed of Transfer shall have been executed to release the Closing Cash Payment
and any distributions from the Escrow Amount in accordance with the wire transfer instructions on
Schedule 2.2(d) to this Agreement (which Schedule shall be delivered to Buyer no later than
three (3) Business Days prior to the Closing Date).

     2.3 Purchase Price Adjustment with respect to Third-Party Expenses.  Not less than seven (7)
days prior to the Closing Date, the Company shall deliver to Buyer a statement (the “Third Party
Expenses Statement”) setting forth all paid Third Party Expenses (including those that will be paid
prior to the Closing Date) and the Company’s good faith best estimate of the amount of all
Third-Party Expenses that will be unpaid or accrued as of the Closing Date. The Third-Party
Expenses Statement shall be certified as having been so prepared by the Chief Financial Officer of
the Company and certifying that there are no other Third Party Expenses that have been paid or are
payable, accrued or owed by the Company or any of its Subsidiaries. The Third Party Expenses
Statement shall include detail reasonably sufficient for Buyer to verify the amounts contained
therein and the computation thereof (where relevant), and be accompanied by any Contracts
documenting the requirement to pay such Third Party Expenses and invoices and receipts relating
thereto evidencing the payment or outstanding nature or basis upon which they have been accrued of
such Third Party Expenses. If Buyer disagrees with any amounts contained, or that amounts should
be included, in such Third Party Expenses Statement, each of the Sellers, the Company and Buyer
shall work together and discuss in good faith such differences (and the Company shall provide
immediate and full access to its personnel, books, records and other information in connection
therewith) in order to resolve same prior to Closing. If the Parties are able to agree, the agreed
and amended Third Party Expenses Statement shall constitute the Third Party Expenses Statement for
purposes of the definition of Adjusted Purchase Price hereunder; and, if not, the Third Party
Expenses Statement initially delivered by Buyer will constitute the Third Party Expenses Statement
for such purposes and Buyer shall have recourse for any Excess Third Party Expenses pursuant to
Article IX hereof. Any Company Third Party Expenses that are not set forth on the Third Party
Expenses Statement

-16-

 

initially delivered by the Company but should have been (such expenses being
“Excess Third Party Expenses”) shall be paid out of the Escrow Amount in accordance with Article
IX.

     2.4 Treatment of Company Options. 

          (a) Assumption of Company Options. Each Company Option outstanding immediately prior
to the Closing, regardless of the exercise prices thereof and whether vested or unvested, will be
assumed by Parent. Each such Company Option so assumed by Parent under this Agreement will
continue to have, and be subject to, the same terms and conditions (including as to vesting) set
forth in the agreement and Company Option Plan governing such Company Option immediately prior to
the effective time of the Closing (the “Effective Time”), except as set forth in Section 2.4(b)
hereof, except that (i) for each holder of Company Options, the aggregate number of Company Options
held by such holder will be exercisable (or will become exercisable in accordance with its terms)
for that number of whole shares of Parent Common Stock equal to the product of the number of
Depositary Receipts that were issuable upon exercise of such Company Options immediately prior to
the Effective Time multiplied by the Conversion Ratio, rounded up to the nearest whole share of
Parent Common Stock (the “Converted Options”), and such holder shall then hold the number of
Converted Options to purchase shares of Parent Common Stock, (ii) the per share exercise price for
the Converted Options to purchase shares of Parent Common Stock issuable upon exercise of such
Converted Option will be equal to the quotient obtained by dividing the exercise price per share of
such Company Option immediately prior to the Effective Time (converted to U.S. dollars by
multiplying such price by the Currency Conversion Rate) by the Conversion Ratio, rounded up to the
nearest whole cent.

          (b) Authorization; Necessary Actions. Prior to the Closing Date, the Company the
Stichting, CBB and Mr. Gerhard Watzinger shall (and each Seller shall cause the Company and the
Stichting to) take all actions reasonably necessary or advisable to allow Parent to effect the
transactions contemplated by Section 2.4(a) under the terms of the Company Option Plan, all option
agreements relating to the Company Option Plan, the Stichting Trust Documents, and any other plan,
agreement or arrangement of the Company or any Subsidiary of the Company, including the amendment
of any of the foregoing or the giving of any notice required under any such plan or agreement
relating to the Company Options. The Stichting undertakes not to amend the terms and conditions of
the Company Share Plans without the prior written consent of Parent and, without limiting the
generality of the foregoing, the Stichting shall pass all appropriate resolutions to allow the
assumption of the Company Options as contemplated by Section 2.4(a) above. In connection with the
foregoing, at the Effective Time, (i) the Stichting and Parent shall enter into an agreement
providing that Parent assumes all obligations of the Stichting under the Company Option Plan
substantially in the form attached hereto as Exhibit F, (ii) the Stichting and CBB shall
enter into a termination agreement substantially in the form attached hereto as Exhibit G,
(iii) the Stichting shall pass resolutions approving the automatic conversion of the Company
Options to Converted Options in the form attached hereto as Exhibit H, and (iv) Parent
shall take all such actions as are reasonably necessary for the assumption and conversion of the
Company Options pursuant to Section 2.4(a), including (A) the reservation for issuance and
authorization for listing on The New York Stock Exchange of the shares of Parent Common Stock
subject to the Converted Options, and (B) the

-17-

 

inclusion for registration of such shares of Parent
Common Stock on Form S-8 within ten (10) days of Parent again becoming current in its public
reporting requirements under the Securities Exchange Act of 1934, as amended.

          (c) Option Exercise Cutoff Date; Actions Necessary. The Company and the Stichting
shall permit the holders of Company Options, to the extent vested at such time, to exercise such
Company Options in accordance with the terms and conditions of the applicable Company Share Plans
(as may be amended) following the date of this Agreement, but not on or following the Option
Exercise Cutoff Date. The Company and the Stichting shall, and shall cause their respective
Affiliates to, execute and deliver all notices and such other instruments, and shall take such
further actions, as may be reasonably necessary or appropriate under the applicable Company Share
Plan(s) relating to the outstanding Company Options to provide the holders of Company Options with
notice of the Option Exercise Cutoff Date and the provisions of this Section 2.4(c), and to
otherwise effect this Section 2.4(c).

          (d) Tax Ruling. Parent shall, in its sole discretion, be entitled to approach the
Dutch tax authorities competent to tax the Company or the holders of the Company Options to seek an
APA/ATR agreement (the “Tax Ruling”) to obtain certainty on the Dutch tax aspects relating to the
assumption of the Company Options by Parent. The Sellers and the Company agree to render Parent or
its Representatives such assistance as may be reasonably required in order to obtain the Tax
Ruling, including granting powers of attorney, as and when required or requested by the Dutch tax
authorities, to prepare, file and submit the Tax Ruling request and enter into the Tax Ruling.

          (e) Deferred Shares. Pursuant to the Deferred Shares Agreement entered into between
the Company and Mr. Gerhard Watzinger effective as of October 21, 2005 (the “Deferred Shares
Agreement”), the Company shall, immediately prior to the Effective Time, deliver to Mr. Gerhard
Watzinger Six-Hundred and Seven Thousand, One-Hundred and Sixteen (607,116) Company Ordinary
Shares, subject to the satisfaction of applicable withholding requirements (the “Deferred Shares”),
which Deferred Shares are included in Exhibit A hereto and sold to Buyer pursuant to this
Agreement. Prior to the Closing Date, the Company and Mr. Gerhard Watzinger will take all actions
reasonably necessary or advisable to effect (i) the intent of this Section 2.4(e) and (ii) the
termination of the Deferred Share Agreement effective as of the Effective Time.

     2.5 Closing; Procedures for Payment of Purchase Price. 

          (a) Closing. Unless this Agreement is earlier terminated pursuant to Article X
hereof, the closing of the Share Purchase (the “Closing”) will take place on a Business Day as
promptly as practicable after the execution and delivery hereof by the Parties hereto, and no less
than three (3) Business Days following satisfaction or waiver of the conditions set forth in
Article VIII hereof (other than those conditions that by their nature are satisfied at the Closing,
but subject to the fulfillment or waiver of those conditions), at the offices of NautaDutilh N.V.,
Rotterdam, The Netherlands, unless another time and/or place is mutually agreed upon in writing by
Buyer and the Company; provided, however, that the Closing shall not occur on a date that is during
the last ten (10) Business Days prior to the last Business Day of a fiscal quarter of Buyer. The
date upon which the Closing actually occurs shall be referred to herein as the “Closing Date.” On
the Closing Date,

-18-

 

the Sellers shall transfer the Shares to Buyer through the execution of the Deed
of Transfer before the Civil Law Notary. The Company shall acknowledge the transfer of the Shares
on the Closing
Date by co-signing the Deed of Transfer and immediately thereafter enter such transfer in its
register of shareholders.

          (b) Closing Payments. On the Closing Date:

               (i) Buyer shall make the Closing Cash Payment in same day funds payable pursuant to
Section 2.2(a) hereof in order to exchange same for all outstanding shares of Company Capital
Stock; and

               (ii) Buyer shall deposit the Escrow Amount with JPMorgan Chase Bank, N.A. (its successor in
interest or other institution selected by Buyer) as escrow agent (the “Escrow Agent”), such deposit
(together with interest and other income thereon) to constitute the escrow fund (the “Escrow Fund”)
and to be governed by the terms set forth herein and in the escrow agreement in substantially the
form attached hereto as Exhibit B (the “Escrow Agreement”), which Buyer and the Sellers’
Representative shall execute and deliver on the Closing Date. Buyer shall be deemed to have
contributed to the Escrow Agent, with respect to each Seller, each such Seller’s Pro Rata Portion
of the Escrow Amount (with amounts greater than or equal to $0.005 rounded up).

          (c) Payment Procedures. At the Closing, the Civil Law Notary will, immediately after
the execution of the Deed of Transfer by the respective Parties, and in accordance with the notary
instruction letter, release the Closing Date Payment, in exchange for the Shares, which the shares
of Company Capital Stock formerly represented, calculated based upon such holder’s Pro Rata Portion
of the Closing Date Payment.

          (d) Post-Closing Payments. The Escrow Agent shall distribute the Escrow Amount to the
Sellers in accordance with each such Seller’s Pro Rata Portion of the Escrow Amount and/or to the
Indemnified Parties in accordance with the terms and conditions of Article IX of this Agreement and
the Escrow Agreement.

     2.6 Withholding Rights.  Buyer and the Escrow Agent shall be entitled to deduct and withhold
from any amounts payable to the Sellers pursuant to this Agreement such amounts as are required to
be deducted and withheld with respect to the making of such payments under the provisions of any
applicable Laws, and to request and receive prior to the Closing Date and at least sixty (60) days
prior to any payment made after the Closing Date any necessary Tax forms, including IRS Form W-9 or
the appropriate IRS Form W-8, as applicable, or any similar information, provided, however, that in
the event any Seller provides to Buyer a valid approval or ruling issued by the applicable
Governmental Entity regarding the withholding (or exemption from withholding) of Taxes from the
Adjusted Purchase Price payable to such Seller (a “Withholding Certificate”), then the withholding
of any amounts from the consideration otherwise payable pursuant to this Agreement to such Seller
shall be made only in accordance with the provisions of such approval or ruling. Any such withheld
amounts shall be treated for all purposes of this Agreement as having been paid to the Person in
respect of which such deduction and withholding was made.

-19-

 

     2.7 Indebtedness.  At the request of Buyer, the Company shall assist Buyer in making appropriate arrangements
(including the preparation of all documentation and the provision of all endorsements required or
reasonably necessary therefor, and arranging for the release of all Liens, financing statements or
other security interests relating thereto) for Buyer (directly or through the Company or any of its
Subsidiaries or Affiliates) to prepay or repay, as the case may be, on or after the Closing Date,
for the benefit of and on behalf of the Company or any of its Subsidiaries, all or a portion of the
Indebtedness of the Company and its Subsidiaries existing as of the Effective Time.

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF THE COMPANYAND THE SELLERS

WITH RESPECT TO THE COMPANY

     The Company (to the extent permitted by any applicable financial assistance Laws) and each of
the Sellers, severally and not jointly, hereby represent and warrant to Buyer, as of the date
hereof and as of the Closing Date, subject to such exceptions as are disclosed in the disclosure
schedule supplied by the Company to Buyer and incorporated as Exhibit D hereto (the
“Disclosure Schedule”) and dated as of the date hereof, as set forth below. Each exception set
forth in the Disclosure Schedule is identified by reference to, or has been grouped under a heading
referring to, a specific section of this Agreement and relates to the representations and
warranties contained in such corresponding section, as well as the representations and warranties
in other sections of this Agreement to the extent that such disclosure is sufficiently detailed to
allow a reasonable person to identify the other sections of this Agreement to which such exceptions
are applicable:

     3.1 Organization of the Company.  The Company is a private company with limited liability duly
organized and validly existing under the laws of The Netherlands and is qualified to do business in
every jurisdiction in which its ownership of property or conduct of business requires it to
qualify. The Company possesses all requisite corporate power and authority and all Permits and
authorizations necessary to own and operate its properties and assets, to carry on its businesses
as now conducted and to carry out the transactions contemplated by this Agreement. The copies of
the Company’s Governing Documents which have been Made Available to Buyer’s counsel incorporate all
amendments made thereto at any time prior to the date of this Agreement and are correct and
complete, and, as of the date hereof, the Board of Directors of the Company has not approved or
proposed any amendment to any of the Company’s Governing Documents. Section 3.1 of the Disclosure
Schedule lists, as of the date hereof, all of the current managing board directors (“statutaire
directie”) of the Company and lists every jurisdiction in which the Company has Employees or
facilities.

     3.2 Company Capital Structure

          (a) The authorized capital stock of the Company consists of (i) 36,120,000 Company Ordinary
Shares, of which 13,443,252 shares are issued and outstanding as of the date hereof, and
(ii) 73,080,000 Company Preference Shares, of which 16,912,464 shares are issued and
outstanding as of the date hereof, and in each case are held legally and beneficially by the
Sellers as set forth in Section 3.2(a) or Section 3.2(b) of

-20-

 

the Disclosure Schedule (free and clear
of all Liens). Except as set forth in the immediately preceding sentence and except as set forth
in Section 3.2(a) of the Disclosure Schedule, the Company does not have as of the date hereof
authorized or outstanding any shares of Company Capital Stock or securities, options, warrants,
calls or rights convertible, exercisable or exchangeable for, or containing any profit
participation features, nor rights (whether Contract rights or otherwise) or options to subscribe
for or to purchase or otherwise acquire, shares of Company Capital Stock or any share or securities
convertible into or exchangeable for shares of Company Capital Stock or any share appreciation
rights, with the exception of the Company Share Plans. The Company is not subject to any
obligation or commitment (contingent or otherwise) to repurchase or otherwise acquire or retire any
shares of Company Capital Stock or any warrants, options or other rights to acquire shares of
Company Capital Stock, or to cause to be issued, delivered, sold, repurchased or redeemed any
shares of Company Capital Stock, other than as expressly set forth in Section 3.2(a) of the
Disclosure Schedule. The Company is under no obligation to grant, extend, accelerate the vesting
of, change the price of, otherwise amend or enter into any such option, warrant, call, right,
commitment or agreement. All outstanding shares of Company Capital Stock are validly issued, fully
paid and non-assessable, and are not subject to any preemptive rights. There are no outstanding or
authorized stock appreciation, phantom stock, profit participation, or other similar, rights with
respect to the Company. As a result of the Share Purchase and except for any unexercised Company
Options, Buyer will be the sole record and beneficial holder of all issued and outstanding shares
of Company Capital Stock and all rights to acquire or receive any shares of Company Capital Stock.

          (b) Section 3.2(b) of the Disclosure Schedule accurately sets forth, as of the date hereof,
the following information with respect to all Company Options and Depository Receipts: the holder
of such Company Option or other right, the type and number of Depository Receipts issuable upon the
exercise of such Company Option or right, the exercise price of such Company Option or right, the
extent such Company Options or rights are vested as of the date hereof, the vesting schedule for
such Company Options or rights and whether such Company Options or rights are subject to
accelerated vesting as a result of the consummation of the Share Purchase. The Company Options or
rights set forth in Section 3.2(b) of the Disclosure Schedule are the only Company Options or
rights outstanding as of the date hereof.

          (c) The holders of Company Preference Shares have not as of the date of this Agreement, and
shall not have as of the Closing, converted any such Company Preference Shares into Company
Ordinary Shares in accordance with Article 31 of the Articles of Association of the Company.

     3.3 Subsidiaries.  Section 3.3 of the Disclosure Schedule lists each Subsidiary of the
Company, the jurisdiction of its incorporation or formation and the Persons with beneficial and
legal ownership of the outstanding shares in the capital of such Subsidiary. Each Subsidiary is
duly organized, validly existing and in good standing (where such concept is applicable) under the
laws of the jurisdiction of its incorporation or formation, possesses all requisite corporate power
and authority and all material Permits and authorizations necessary to own its properties and to
carry on its businesses as now
being conducted. All of the outstanding shares in the capital of each Subsidiary are validly
issued, fully paid up and non-assessable, and not subject to any preemptive rights. The Company or
another Subsidiary is the beneficial owner and owner of record of all of the

-21-

 

capital stock of each
Subsidiary, free and clear of any Liens and not subject to any option or right to purchase any such
shares. The copies of the each Subsidiary’s Governing Documents which have been Made Available to
Buyer’s counsel and incorporate all amendments made thereto at any time prior to the date of this
Agreement and are correct and complete, and, as of the date hereof, the Board of Directors of the
Company and each of its Subsidiaries has not approved or proposed any amendment to any such
Subsidiary Governing Documents. Except as set forth in this Section 3.3 and except as set forth in
Section 3.3 of the Disclosure Schedule, none of the Company’s Subsidiaries has authorized or
outstanding any shares of capital stock of such Subsidiary or securities, options, warrants, calls
or rights convertible, exercisable or exchangeable for, or containing any profit participation
features, nor rights (whether Contract rights or otherwise), or options to subscribe for or to
purchase or otherwise acquire, shares of capital stock of such Subsidiary or any share or
securities convertible into or exchangeable for shares of capital stock of such Subsidiary or any
share appreciation rights. None of the Company’s Subsidiaries are under any obligation to grant,
extend, accelerate the vesting of, change the price of, otherwise amend or enter into any such
option, warrant, call, right, commitment or agreement. None of the Company’s Subsidiaries are
subject to any obligation or commitment (contingent or otherwise) to repurchase or otherwise
acquire or retire any shares of capital stock of such Subsidiary or any warrants, options or other
rights to acquire shares of capital stock of such Subsidiary or cause to be issued, delivered,
sold, repurchased or redeemed, any shares of capital stock of such Subsidiary. There are no
outstanding or authorized stock appreciation, phantom stock, profit participation, or other
similar, rights with respect to the any of the Company’s Subsidiaries.

     3.4 Authority and Enforceability; No Conflicts.  The Company has all requisite power and
authority to enter into the Agreement and any Ancillary Agreements to which it is a party and to
consummate the transactions contemplated hereby and thereby. The Company has duly authorized the
execution of this Agreement by all necessary action. This Agreement constitutes a valid and
binding obligation of the Company, enforceable against the Company in accordance with its terms.
The execution and delivery by the Company of this Agreement, and the fulfillment of and compliance
with the respective terms hereof by the Company or any Seller does not and will not (a) conflict
with, or result in any violation or breach of, any provision of the Company Governing Documents or
any Subsidiary’s Governing Documents, (b) conflict with, or result in any material violation or
breach of, or constitute (with or without notice or lapse of time, or both) a default (or give rise
to a right of termination, cancellation, modification or acceleration of any obligation or loss of
any material benefit) under, require a consent or waiver under, constitute a change in control
under, require the payment of a penalty or increased fees under or result in the imposition of
Liens on the Company’s or any of its Subsidiaries’ assets under, any of the terms, conditions or
provisions of any Contract to which the Company or any of its Subsidiaries is a party or by which
any of them or any of their assets are bound, or (c) conflict with or violate, in any material
respect, any permit, concession, franchise, license, judgment, injunction, Order, writ, decree, Law
applicable to the Company or any of its Subsidiaries or any of its or their respective properties
or assets.

-22-

 

3.5 Financial Statements; Internal Controls.

          (a) The Company has Made Available to Buyer true, accurate and complete copies of the
Company’s (i) audited, combined and consolidated balance sheets as of December 31, 2004, 2005 and
2006 and the related audited statements of income, cash flows and shareholders’ equity for the
fiscal years ended December 31, 2004, 2005 and 2006 (including the related notes and independent
auditors reports thereon) (the “Annual Financial Statements”) and (ii) the unaudited consolidated
balance sheet as of June 30, 2007 and the related unaudited consolidated statements of income, cash
flows and shareholders’ equity for the six months ended June 30, 2007 (the “Unaudited Financial
Statements”; and, together with the Annual Financial Statements, the “Financial Statements”; the
balance sheet included in the Unaudited Financial Statements referred to herein as the “Company
Balance Sheet”, and the date of such balance sheet, the “Company Balance Sheet Date”). Each of the
foregoing financial statements (including in all cases the notes thereto, if any) is accurate and
complete, is consistent with the books and records of the Company (which, in turn, are accurate and
complete), fairly presents the financial condition and operating results of the Company and its
Subsidiaries and has been prepared in accordance with Dutch GAAP consistently applied throughout
the periods covered thereby (or, with respect to the Annual Financial Statements for 2007 and the
Unaudited Financial Statements, IFRS consistently applied throughout the periods covered thereby),
subject in the case of the Unaudited Financial Statements to the absence of footnotes and normal
year-end adjustments, which are not expected to be material.

          (b) To the knowledge of the Company, the Company and its Subsidiaries maintain proper and
adequate internal accounting controls that provide assurance that (i) transactions are executed
with management’s authorization, and (ii) transactions are recorded as necessary to permit
preparation of their financial statements and to maintain accountability for their assets.

          (c) As at September 30, 2007, the Company and its consolidated Subsidiaries had cash on the
balance sheet in an amount equal to or greater than €6,800,000.

     3.6 No Undisclosed Liabilities.  The Company and its Subsidiaries do not have any Liabilities
required to be disclosed in, reflected in or reserved against in the consolidated balance sheet of
the Company and its Subsidiaries in accordance with IFRS, other than (a) Liabilities reflected in
the Company Balance Sheet and (b) normal or recurring Liabilities incurred since the Company
Balance Sheet Date in the ordinary course of business consistent with past practices.

     3.7 No Material Adverse Effect.  Since the Company Balance Sheet Date, there has occurred no
fact, event or circumstance which has had, or would reasonably be expected to have, a Company
Material Adverse Effect. Since the Company Balance Sheet Date, the Company and each of its
Subsidiaries has conducted its
business only in the ordinary course of business of the Company and its Subsidiaries
consistent with past practice.

     3.8 Absence of Certain Developments.  Except as expressly permitted by this Agreement or as
set forth in Section 3.8 of the Disclosure Schedule, since the Company Balance Sheet Date through
the date of this Agreement, neither the Company nor any of its Subsidiaries has:

-23-

 

          (a) issued, granted, delivered or sold or authorized or proposed the issuance, grant, delivery
or sale of, or purchase or propose the purchase of, any shares of Company Capital Stock or shares
of any capital stock of any Subsidiary of the Company or any securities convertible into, or
subscriptions, rights, warrants or options to acquire, or other agreements or commitments of any
character obligating it to issue or purchase any such shares or other convertible securities, other
than (i) issuances of Company Capital Stock pursuant to exercises of Company Options or warrants to
purchase Company Capital Stock in accordance with their terms, and (ii) repurchases at cost of
Company Ordinary Shares upon termination of a service provided and pursuant to the terms of a
Contract;

          (b) incurred any Indebtedness or guaranteed any Indebtedness for borrowed money or issued or
sold any debt securities or other obligations of others, in each case, on an aggregate basis, in
excess of €100,000, except current Liabilities incurred in the ordinary course of business of
the Company and its Subsidiaries;

          (c) paid, discharged or satisfied any Lien or Liability in an amount in excess of €50,000
in any one case, or €100,000 in the aggregate, except for current Liabilities paid, discharged
or satisfied in the ordinary course of business consistent with past practices;

          (d) declared, set aside, or paid any dividends on or made any other distributions (whether in
cash, stock or property) in respect of any Company Capital Stock or any capital stock of any
Subsidiary of the Company, or split, combined or reclassified any Company Capital Stock or any
capital stock of any Subsidiary of the Company or issued or authorized the issuance of any other
securities in respect of, in lieu of or in substitution for shares of Company Capital Stock or
shares of any capital stock of any Subsidiary of the Company, or repurchased, redeemed or otherwise
acquired, directly or indirectly, any shares of Company Capital Stock or shares of any capital
stock of any Subsidiary of the Company (or options, warrants or other rights exercisable therefor),
except in accordance with the agreements evidencing Company Options;

          (e) mortgaged or pledged any of its properties or assets or the properties or assets of any of
its Subsidiaries or subjected them to any Lien, except for Permitted Liens;

          (f) sold, assigned, leased, licensed or otherwise transferred any of its tangible assets in
excess of €150,000, except in the ordinary course of business consistent with past practices;

          (g) initiated, compromised or settled any Action or canceled, compromised, waived, or released
any right or claim in excess of €100,000 or that is otherwise material to the Company or its
Subsidiaries;

          (h) (i) transferred ownership of or exclusively licensed any Company Intellectual Property or
entered into any Contract for the transfer of ownership or the exclusive license of any Company
Intellectual Property to any Person, other than non-exclusive licenses to customers of the Company
entered into in the ordinary course of business consistent with past practices, or (ii)
non-exclusively licensed any Company Intellectual Property or entered into any Contract for the
non-exclusive license of any Company Intellectual Property to any Person, other than non-exclusive

-24-

 

licenses to customers of the Company entered into in the ordinary course of business consistent
with past practices;

          (i) made or granted any bonus or any wage or salary increase to any employee or group of
employees in excess of €100,000 (except as required by pre-existing contracts described in
Section 3.8(i) of the Disclosure Schedule), granted any severance or termination pay (in cash or
otherwise) to any Company Employee, including any officer of the Company or its Subsidiaries, or
made or granted any increase in any Company Employee Plan or arrangement, or amended or terminated
any existing Company Employee Plan or arrangement or adopted any new Company Employee Plan or
arrangement;

          (j) suffered any extraordinary losses in excess of €100,000 in the aggregate;

          (k) made any capital expenditures or commitments therefor that aggregate in excess of
€200,000 or otherwise material to the Company or its Subsidiaries;

          (l) delayed or postponed the payment of any accounts payable or commissions or any other
liability or obligation by more than 60 days or agreed or negotiated with any party to extend the
payment date of any accounts payable or commissions or any other liability or obligation by more
than 60 days or accelerated the collection of (or discounted) any accounts or notes receivable;

          (m) made any loans or advances to, in an amount in excess of €100,000 in any one case, or
guarantees for the benefit of, any Person (including incorporation of any Subsidiary), other than
advances in the ordinary course of business consistent with past practices;

          (n) made any investments in any Person in excess of €200,000;

          (o) made any charitable contributions or pledges exceeding in the aggregate €100,000 or
made any political contributions;

          (p) suffered any damage, destruction or casualty loss exceeding in the aggregate €100,000,
not covered by any insurance policies;

          (q) made any change in any method of accounting or accounting policies or procedures,
including with respect to reserves for excess or obsolete inventory, doubtful accounts or other
reserves, depreciation or amortization policies or rates, billing and invoicing policies, or
payment or collection policies or practices, except insofar as may have been required by IFRS or
required to change any assumption underlying, or method of calculating, any bad debt, contingency
or other reserve or revalued any of the assets (whether tangible or intangible) of the Company or
any of its Subsidiaries;

          (r) entered into or renewed any Contract or arrangement that materially limits or restricts
the Company or any of its Subsidiaries from engaging or competing in any line of business or in any
geographical area (other than confidentiality agreements or other similar arrangements

-25-

 

entered into
in the ordinary course of business and which would not, taken as a whole, materially restrict the
operation of the business of the Company as presently conducted) or that involves exclusive terms
or most-favored nation terms of any kind;

          (s) acquire or agree to acquire by merging or consolidating with, or by purchasing any assets
or equity securities of, or by any other manner, any business or any Entity or division thereof, or
otherwise acquire or agree to acquire any assets which are material, individually or in the
aggregate, to the Company’s or any of its Subsidiaries’ businesses; or

          (t) agreed or committed, whether orally or in writing, to do any of the actions described in
Sections 3.8(a) through 3.8(s) above.

     3.9 Tax Matters. In each case solely with respect to the period from and including the tax
year 2005:

          (a) Registration. The Company and each of its Subsidiaries have been duly and timely
registered for Tax purposes in their country of residence.

          (b) Filing Requirements. The Company and any of its Subsidiaries have duly and timely
filed, or caused to be filed with all appropriate Governmental Entities, all Tax Returns, reports
and declarations required by applicable Laws to have been filed by or with respect to any of them,
either separately or as a member of a group of companies, each of which returns, reports and
declarations correctly reflects the Tax Liabilities and all other information required to be
reported therein. Neither the Company nor any of its Subsidiaries has waived the statute of
limitations on or otherwise extended the period for the assessment or collection of any Tax.

          (c) Tax Provision and Capital Gains. All Tax required to be paid or withheld by the
Company or any of its Subsidiaries in respect of any taxable period or portion thereof ending on or
prior to the Closing Date (all such periods, the “Pre-Closing Tax Period”) and in the pre-Closing
part of the Pre- to Post-Closing Tax Period, including any and all Tax required to be paid or
withheld as a result of entering into this Agreement and the execution thereof, have been paid or
withheld or will be paid or withheld in full or have been fully provisioned in the Company Balance
Sheet. The amount of provision for deferred Tax in the Company Balance Sheet is adequate and fully
in accordance with IFRS. Neither the Company nor any of its Subsidiaries has incurred any
Liability for Taxes since the Company Balance Sheet Date other than in the ordinary course of
business.

          (d) Full Disclosure. The Sellers and the Company have disclosed fully and completely
all facts, circumstances and have submitted to Buyer all documents which influence, in any material
respect, the position of the Company or any of its Subsidiaries regarding Tax, including but not
limited to any agreement, ruling, or compromise with any Tax Authority. Neither the Company nor
any of its Subsidiaries has the intention to conclude up to the Closing Date with any Tax Authority
any agreement, ruling or compromise in connection with Tax. The entering into this
Agreement and the execution thereof will have no material impact on the position of the
Company or any of its Subsidiaries regarding Tax, including but not limited to any agreement,
ruling, or compromise with any Tax Authority and the application of favorable Tax regimes.

-26-

 

          (e) No Disputes, Objections, Appeals, Collection Procedures, Reminders or Warrants.
No disputes exist and neither the Sellers nor the Company has any knowledge of circumstances or
events that could reasonably be expected to give rise to a material dispute with any Tax Authority
regarding the Tax position of the Company or any of its Subsidiaries or any of their properties,
assets or income or regarding the Tax Returns filed by the Company or any of its Subsidiaries. No
audits or investigations are to the knowledge of the Company presently being made by any Tax
Authority or are expected regarding the Tax position of the Company or any of its Subsidiaries or
any of their properties, assets or income or regarding the Tax Returns filed by the Company or any
of its Subsidiaries. No requests for exchange of information are pending regarding Tax relating to
the Company or any of its Subsidiaries or their business relations. No objection or appeal
regarding Tax is presently pending or, to the knowledge of the Company, will be filed prior to
Closing with any Tax Authority or any competent court or courts. No collection procedures have
been initiated against the Company or any of its Subsidiaries or any of their properties, assets or
income for account of any Tax. Neither the Company nor any of its Subsidiaries has received any
reminders (“notices”) or warrants relating to the payment of Tax.

          (f) No Criminal Investigation. Neither the Company nor any of its Subsidiaries has to
the Company’s knowledge ever been the subject of a criminal investigation, accused or found guilty
of fraud, relating to or involving Tax.

          (g) Chain Liability. Neither the Company nor any of its Subsidiaries has acted during
the last six years as contractor or subcontractor as defined in article 35 of the Dutch Collection
Act 1990 (“Invorderingswet 1990”) or as a recipient of workers as defined in article 34 of the
Dutch Collection Act 1990 (“Invorderingswet 1990”) or other comparable provisions of applicable
Laws in other countries where the Company or any of its Subsidiaries are resident.

          (h) No Liquidator, Managing Director or Executor of a Will. Neither the Company nor
any of its Subsidiaries has ever acted as the liquidator (“vereffenaar”) of any entity in the sense
of the Dutch General Tax Act (“Algemene wet inzake rijksbelastingen”). Neither the Company nor any
of its Subsidiaries has ever acted as a managing director of any entity in the sense of the Dutch
General Tax Act (“Lichaam in de zin van de Algemene wet inzake rijksbelastingen”) or the Dutch
Collection Act 1990 (“Invorderingswet 1990”). Neither the Company nor any of its Subsidiaries has
ever acted as an executor of a will (“executeur-testamentair”).

          (i) Recapture Tax Exemptions. Neither the Company nor any of its Subsidiaries has
claimed or been granted exemptions from Tax, roll-over relief or other Tax facilities (including
investment Tax credits and other similar Tax benefits) during the last six (6) years before the
Closing Date, which are annulled and give rise to Tax in the post-Closing part of the Pre- to
Post-Closing Tax Period or in Post-Closing Tax Periods.

          (j) No Material Non-Deductible Payments. Neither the Company nor any of its
Subsidiaries has any obligations to make any material future payment which will be prevented from
being deductible for corporate income tax purposes, except for the non-deductibility of
interest expenses for Dutch corporate income tax purposes as laid down in paragraph 6 under (h) of
the written settlement agreement that is referred to in subsection (m) of this Section 3.9.

-27-

 

          (k) Transfer Pricing. All transactions between the Company and any of its
Subsidiaries and all transactions between the Company and any of its Subsidiaries and the Sellers
were effected on arm’s length terms. To the Company’s knowledge, no transactions or arrangements
involving the Company or any of its Subsidiaries have taken place or are in existence which are
such that any provision relating to transfer pricing might be invoked by any applicable
Governmental Entity, affecting the Tax position of the Company or any of its Subsidiaries.

          (l) Tax Residence/Permanent Establishment. Neither the Company nor any of its
Subsidiaries is treated for any Tax purpose as resident in a country other than the country of its
incorporation and neither the Company nor any of its Subsidiaries has, or has had within the past
ten years, a branch, agency or permanent establishment in a country other than the country of its
incorporation, or is considered to be a branch, agency or permanent establishment of a company in a
country resident in another country.

          (m) Settlement. A written settlement agreement has been reached with a competent Tax
Authority on (i) the place of residence of Safeboot N.V., (ii) the application of the participation
exemption (deelnemingsvrijstelling) to the shares in Safeboot N.V., (iii) the absence of a
permanent establishment of Safeboot N.V. in The Netherlands and (iv) the transfer pricing to be
applied to the intellectual property that is licensed from Safeboot N.V. and none of the Company
nor any of its Subsidiaries has deviated in any material respect from the terms and conditions of
such settlement agreement, including the critical assumptions in paragraph 6 of such settlement
agreement, or otherwise conducted its affairs in a manner that would cause the principles of such
settlement agreement or advance ruling to be inapplicable.

          (n) Non-deductible Interest. Neither the Company nor any of its Subsidiaries has
Indebtedness outstanding on which interest would be wholly or partly (temporarily) not deductible
under article 10(1)(d), 10 a, 10 b, 10 d and/or, with respect to any period prior to January 1,
2007, 15 ad of the Dutch Corporate Income Tax Act 1969.

          (o) Participation Exemption. All shareholding interests of the Company and the
Subsidiaries qualify as a participation within the meaning of article 13 of the Dutch Corporate
Income Tax Act 1969 and as a result thereof, the income derived from such shareholding interests,
including dividends and capital gains, is fully exempt from Dutch corporate income tax at the level
of the Company and the Subsidiaries. Neither the Sellers nor any of the Company or any of its
Subsidiaries qualifies or qualified as an investment institution within the meaning of article 28
or article 28b of the Dutch Corporate Income Tax Act 1969.

          (p) Written-off Receivables. Neither the Company nor any of its Subsidiaries has
written off receivables on affiliated entities (within the meaning of article 10a, paragraph 4 of
the Dutch Corporate Income Tax Act 1969) against taxable income.

          (q) Conversion Permanent Establishment into Subsidiary. Neither the Company nor any
of its Subsidiaries has a shareholding in a Subsidiary to which the Dutch participation exemption
applies and which runs foreign business operations which were formerly operated as a

-28-

 

permanent
establishment by the Company or any of its affiliated entities within the meaning of article 10a,
paragraph 4 of the Dutch Corporate Income Tax Act 1969.

          (r) Depreciation Subsidiaries. Neither the Company nor any of its Subsidiaries has
depreciated for Tax purposes a shareholding in a Subsidiary to which the Dutch participation
exemption applies.

          (s) Third Party Tax. Neither the Company nor any of its Subsidiaries will be held
liable for Tax due by any third party other than the Company or any of its Subsidiaries within the
meaning of the Dutch Collection Act 1990 (“Invorderingswet 1990”).

     3.10 Real Property. Section 3.10 of the Disclosure Schedule sets forth, as of the date
hereof, a list of all Contracts, licenses or other agreements for the use or occupancy of any real
property (the “Leased Real Property”) (including all amendments, extensions, renewals, guaranties
and other agreements with respect thereto) held by the Company or any of its Subsidiaries
(collectively, the “Leases”) and the address for each Leased Real Property. The Company has Made
Available to Buyer a true and complete copy of each written Lease, and in the case of any oral
Leases, a written summary of the material terms thereof. Except as set forth in Section 3.10 of
the Disclosure Schedule, with respect to each of the Leases: to the Company’s knowledge (i) the
Lease is legal, valid, binding and in full force and effect; (ii) the consummation of the
transactions contemplated hereunder will not result in a breach of or default or consent
requirement under the Lease or otherwise cause the Lease to cease to be legal, valid and binding,
enforceable and in full force and effect on identical terms following the Closing, (iii) neither
the Company nor any of its Subsidiaries nor, to the Company’s knowledge, any other party to the
Lease is in breach or default under the Lease, and no event has occurred or circumstance exists
which, with the delivery of notice, passage of time or both, would constitute such a breach or
default or permit the termination, modification of rent under the Lease; (iv) no party to the Lease
has repudiated any term thereof, and there are no disputes or oral agreements or forbearance
programs in effect with respect to the Lease; and (v) neither the Company or any of its
Subsidiaries has assigned, subleased, mortgaged, deeded in trust or otherwise transferred or
encumbered the Lease. Neither the Company nor any of its Subsidiaries owns any real property or
any interest in real property. 

     3.11 Assets. 

          (a) Except as set forth in Section 3.11(a) of the Disclosure Schedule, the Company and each of
its Subsidiaries, as the case may be, has good and valid title to, a valid leasehold interest in,
or a valid license to use, the properties and assets, whether tangible or intangible, used by it,
located on its premises and shown on the Company Balance Sheet or acquired thereafter, free and
clear of all Liens, except for properties and assets disposed of in the
ordinary course of business since the date of the Company Balance Sheet the details of which
have been Made Available to Buyer prior to the date hereof, and except for Liens disclosed on the
Company Balance Sheet (including any notes thereto) and Permitted Liens.

          (b) Except as set forth in Section 3.11(b) of the Disclosure Schedule, all of the Company’s
and its Subsidiaries’ buildings, equipment, fixtures, improvements and other tangible

-29-

 

assets
(whether owned or leased) are in satisfactory condition and repair (ordinary wear and tear
excepted), are operational and are fit for use in the ordinary course of the Company’s or its
Subsidiaries’, business as presently conducted. All such assets have been installed and maintained
in all material respects in accordance with all applicable Laws, regulations and ordinances.

          (c) Except as set forth in Section 3.11(c) of the Disclosure Schedule, each of the Company and
its Subsidiaries owns, has a valid leasehold interest in, or has a valid license to use, all of the
material assets, properties and rights, whether tangible or intangible, necessary for the conduct
of its business as presently conducted.

     3.12 Intellectual Property. 

          (a) Section 3.12(a) of the Disclosure Schedule contains a complete and accurate list, as of
the date hereof, of (i) all patents, patent applications and other Intellectual Property Rights
that are the subject of an application, registration or filing with a Governmental Entity owned or
filed on behalf of or in the name of the Company or any of its Subsidiaries, and (ii) all trade
names, logos, corporate names and brand names used by the Company or any of its Subsidiaries,
specifying the products or services with respect to which such marks or names are used and internet
domain names used by the Company or any of its Subsidiaries.

          (b) Section 3.12(b) of the Disclosure Schedule also contains a complete and accurate list, as
of the date hereof, of all Contracts pursuant to which licenses or other rights have been granted
by the Company or any of its Subsidiaries to any third party with respect to any Intellectual
Property Rights (“Out-bound IP Agreements”), and all Contracts pursuant to which licenses and other
rights have been granted by any third party to the Company or any of its Subsidiaries with respect
to any Intellectual Property Rights (“In-bound IP Agreements”), except (i) Out-bound IP Agreements
with customers entered into in the ordinary course of business consistent with past practices, (ii)
Out-bound IP Agreements with distributors entered into in the ordinary course of business
consistent with past practices, and (iii) any licenses granted to the Company or any of its
Subsidiaries of unmodified, mass market software, pursuant to the licensor’s ordinary, generally
commercially available license terms, having an aggregate value for all related licenses thereof of
less than €50,000 (“Generally Commercially Available Code”), in each case identifying the
subject Intellectual Property Rights.

          (c) Other than Intellectual Property Rights licensed to the Company under (i) the In-Bound IP
Agreements listed in Section 3.12(b) of the Disclosure Schedule, and (ii) licenses for Generally
Commercially Available Code, and other than as set out on Section 3.12(c) of the
Disclosure Schedule, the Company exclusively owns all right, title and interest in all Company
Intellectual Property. The Company and its Subsidiaries own (to the extent such Intellectual
Property Rights are capable of ownership) and possess all right, title and interest to, or have the
right to use pursuant to a valid enforceable written license, all Intellectual Property Rights
necessary for the operation of their businesses as presently conducted (including, without
limitation, the right to sell, license or otherwise distribute the Company software), free and
clear of all Liens.

-30-

 

          (d) It is not and will not be necessary to utilize any Intellectual Property Rights of any of
the Company’s or its Subsidiaries’ employees developed, invented or made prior to their employment
by the Company or any of its Subsidiaries except for any such Intellectual Property Rights that
have previously been assigned to the Company or any of its Subsidiaries. Except as set forth in
Section 3.12(d) of the Disclosure Schedules, the loss or expiration of any Intellectual Property
Right or related group of Intellectual Property Rights owned or used by the Company or any of its
Subsidiaries has not had and would not reasonably be expected to have a Company Material Adverse
Effect, and no loss or expiration of any Intellectual Property Right is threatened in writing,
pending or, to the Company’s knowledge, reasonably foreseeable. The Company has taken commercially
reasonable steps to maintain and protect the Company Intellectual Property. To the Company’s
knowledge, the owners of any Intellectual Property Rights licensed to the Company or any of its
Subsidiaries have taken commercially reasonable action to maintain and protect the Intellectual
Property Rights which are subject to such licenses.

          (e) Except as set forth in Section 3.12(e) of the Disclosure Schedule, there have been no
claims made against the Company or any of its Subsidiaries asserting the invalidity, misuse or
unenforceability of any of the Company Intellectual Property and, to the Company’s knowledge, there
is no basis for any such claim. Neither the Company nor any of its Subsidiaries have received any
notices of, and has no knowledge of any facts which indicate a reasonable possibility of, any
infringement or misappropriation by the Company or its Subsidiaries of, or conflict by the Company
or its Subsidiaries with, any third-party Intellectual Property Rights (including without
limitation any written demand or request that the Company or any of its Subsidiaries license any
rights not already under license from a third party).

          (f) The conduct of the Company’s and its Subsidiaries’ businesses has not, does not and, when
conducted following the Closing in the manner as conducted as of the date of this Agreement, will
not infringe, misappropriate or otherwise violate any Intellectual Property Rights of other
Persons, and to the Company’s knowledge, the Company Intellectual Property Rights have not been and
are not being infringed, misappropriated or otherwise violated by other Persons.

          (g) Neither this Agreement, nor the transactions contemplated by this Agreement, nor any
subsequent merger or assignment of the Company, its Subsidiaries or the assets of either into or
with Buyer or any of Buyer’s Affiliates, will (i) have any effect on the Company’s (or its
Subsidiaries’) right, title or interest in and to their Intellectual Property Rights (and all of
such Intellectual Property Rights shall be owned or available for use by the Company or any of its
Subsidiaries on identical terms and conditions immediately after the Closing), or (ii) result in
the Company or any of its Subsidiaries (A) granting to any third party any right to or with respect
to any Intellectual Property Rights owned by, or licensed to, the Company or any of its
Subsidiaries (other than rights granted by the Company or any of its Subsidiaries on or prior to
the Closing Date under
Intellectual Property Rights owned by the Company or any of its Subsidiaries as of the Closing
Date), (B) being bound by, or subject to, any non-compete or other material restriction on its
freedom to engage in, participate in, operate or compete in any line of business, or (C) being
obligated to pay any royalties or other license fees with respect to Intellectual Property Rights
of any third party in excess of those payable by the Company or any of its Subsidiaries in the
absence of

-31-

 

this Agreement or the transactions contemplated hereby; provided, however, that the
representations made in this Section 3.12(g) will not be deemed to be breached as a result of the
operation of provisions contained in a Contract to which Buyer is a party (but to which the Company
and any of its Subsidiaries is not).

          (h) All Persons who have participated in the creation or development for the Company or any of
its Subsidiaries of any Technology or Intellectual Property Rights (including the Company’s
web site software, scripts and content, and also including the Company’s transaction processing
software, databases, and interfaces) have executed and delivered to the Company a valid and
enforceable agreement providing for the non-disclosure by such Person of any confidential
information of the Company and its Subsidiaries, and providing for the assignment by such Person to
the Company of any Intellectual Property Rights arising out of such Person’s employment by, work
for, or contract with the Company or any of its Subsidiaries, all pursuant to agreements with such
Persons and the Company Made Available to Buyer.

          (i) Except as set forth in Section 3.12(i) of the Disclosure Schedule, neither the Company nor
any of its Subsidiaries has used Open Source Material in any manner that (i) requires the
disclosure or distribution in source code form of any Technology owned by the Company or any of its
Subsidiaries, or any portion of any Company product other than such Open Source Material,
(ii) requires the licensing of any Technology owned by the Company or any of its Subsidiaries, or
any portion of any Company product other than such Open Source Material, for the purpose of making
derivative works, (iii) imposes any restriction on the consideration to be charged for the
distribution of any Company product or any Technology owned by the Company or any of its
Subsidiaries, (iv) creates obligations for the Company or any of its Subsidiaries with respect to
Company Intellectual Property or grants to any third party, any rights or immunities under Company
Intellectual Property, or (v) impose any other material limitation, restriction or condition on the
right of the Company to use or distribute any Company product or service.

          (j) Except as set forth in Section 3.12(j) of the Disclosure Schedule, neither the Company,
any of its Subsidiaries, nor any other Person acting on its behalf has disclosed, delivered or
licensed to any Person, agreed to disclose, deliver or license to any Person, or permitted the
disclosure or delivery to any escrow agent or other Person of, any source code for any Company
product except for disclosures to employees, contractors or consultants under agreements that
prohibit use or disclosure except in the performances of services to the Company or any Subsidiary
thereof. Neither this Agreement, nor the transactions contemplated by this Agreement, nor any
subsequent merger or assignment of Company, its Subsidiaries or the assets of either into or with
Buyer or any of Buyer’s Affiliates, will result in, or entitle any Person to demand, the
disclosure, delivery or license of any source code for any Company product to any Person.

          (k) Neither the Company nor any of its Subsidiaries is a party to any Contract with any
Governmental Entity in which any rights are granted under any Company Intellectual Property other
than commercial rights with respect to the use of Company Products.

-32-

 

     3.13 Material Contracts.  Except as set forth in Section 3.13 of the Disclosure Schedule,
neither the Company nor any of its Subsidiaries is, as of the date of this Agreement, a party to or
bound (whether orally or in writing) by:

          (a) any pension, profit sharing, share option, employee share purchase or other plan or
arrangement providing for deferred or other compensation to employees or any other employee benefit
plan, arrangement or practice, whether formal or informal;

          (b) any collective bargaining agreement or any other contract with any labor union, or any
severance agreements, programs, policies or arrangements;

          (c) any management agreement, any Contract for the employment of any managing director
(“statutair bestuurder”), a senior manager, employee or consultant earning base compensation in
excess of €100,000, or any Person involved in the development of the Safeboot software on a
full-time, part-time, consulting or other basis or any Contract providing for the payment of any
cash or other compensation by the Company or its Subsidiaries or benefits upon the consummation of
the transactions contemplated hereby; and any Contract providing for indemnification obligations to
any present or former director, officer or employee of the Company or any of its Subsidiaries;

          (d) any Contract (other than any customer Contract that involves maintenance revenue of less
than €100,000 on an annual basis) involving consideration in excess of €150,000 requiring the
consent of any party thereto upon a change in control of the Company, or containing any provision
which would result in a modification of any rights or obligations of any party thereunder upon a
change in control of the Company;

          (e) any Contract having a value in excess of €150,000 under which it has advanced or loaned
monies to any other Person (in each case, other than advances to the Company’s employees in the
ordinary course of business of the Company and its Subsidiaries);

          (f) any Contract or indenture having a value in excess of €100,000 relating to borrowed
money or other Indebtedness or the mortgaging, pledging or otherwise, without reference to value,
placing a Lien on any material asset or material group of assets of the Company or any of its
Subsidiaries or any letter of credit arrangements;

          (g) any guaranty of any obligation for borrowed money or otherwise having a value in excess of
€100,000 (other than endorsements made for collection in the ordinary course of business);

          (h) any Contract under which the Company is lessee of or holds or operates any property, owned
by any other Person;

          (i) any Contract under which the Company is lessor of or permits any third party to hold or
operate any property, real or personal, owned or controlled by the Company where the annual
payments are in excess of €50,000;

-33-

 

          (j) any Contract regarding ownership and rights with regard to work produced by senior
managers or employees having a direct and material role in the development of any Intellectual
Property Right held by the Company or any of its Subsidiaries;

          (k) any Contract or group of related Contracts with the same party or group of affiliated
parties for the purchase of supplies, products, equipment or other personal property (other than
computer leasing Contracts) or for the receipt of services under which the annual payments for such
products and services is in excess of €150,000;

          (l) any Contract or group of related Contracts with the same party or group of affiliated
parties for the sale of supplies, products, equipment or other personal property or for the
furnishing of services under which the annual payments for such products or services due from the
Company or any of its Subsidiaries exceed €150,000;

          (m) any Contract or group of related contracts with the same party or group of affiliated
parties continuing over a period of more than six (6) months from the date or dates thereof, not
terminable by the Company or any of its Subsidiaries upon sixty (60) days’ notice without penalty
and involving more than €150,000 per year;

          (n) any Contract relating to the marketing, sale, advertising or promotion of the services of
the Company or any of its Subsidiaries having future obligations in excess of €150,000 that are
not terminable by the Company or any of its Subsidiaries on no more than thirty (30) days’ notice
without penalty;

          (o) any Contracts relating to the ownership of or investments in any business or enterprise,
including investments in joint ventures and minority equity investments having a value in excess of
€150,000;

          (p) any warranty or similar Contract with a value in excess of €150,000 with respect to its
services or its products sold, leased or licensed which contains terms and conditions that differ
in any material respect from the Company’s or any of its Subsidiaries’ standard warranty terms and
conditions;

          (q) any (i) In-bound IP Agreements or (ii) Out-bound IP Agreements required to be listed on
Section 3.12(b) of the Disclosure Schedule;

          (r) any Contract under which the Company or any of its Subsidiaries has granted to any Person
any registration rights to force the Company to list its shares on any exchange or facilitate to
the public sale of its shares;

          (s) procuration (“procuratie”) to any Person other than a senior manager;

          (t) any Contract prohibiting the Company or any of its Subsidiaries from freely engaging in
any business or competing anywhere in the world or to exercise, use, modify, maintain,

-34-

 

support,
transfer, license, distribute, exploit or enforce any Company Intellectual Property Rights or
Company Products;

          (u) any Contract involving maintenance or service obligations on the part of the Company or
any of its Subsidiaries involving annual revenues to the Company or its Subsidiaries in excess of
€75,000 that contains an exclusivity or “most-favored-nation” provision;

          (v) any Contract, commitment or undertaking with any Governmental Entity having a value in
excess of €150,000;

          (w) any Contract with a third-party consultant, sales representative, distributor, dealer or
other independent contractor to which either the Company or a Subsidiary is a party under which the
Company made any payments in excess of €100,000 in the aggregate within the preceding twelve
(12) month period;

          (x) any Contract or commitment containing any material support, maintenance or service
obligation on the part of the Company or any of its Subsidiaries involving annual revenues to the
Company or its Subsidiaries in excess of €100,000, other than those obligations that are
terminable by the Company or any of its Subsidiaries on no more than thirty (30) days’ notice
without material Liability or financial obligation to the Company or its Subsidiaries;

          (y) any Contract which is material to its operations or business prospects or involves an
annual consideration in excess of €150,000 not made in the ordinary course of business
consistent with past practices; or

          (z) any Contract with any Top Distributor or any OEM Partner.

All of the contracts, agreements and instruments set forth or required to be set forth in Section
3.13 of the Disclosure Schedule (each a “Material Contract”), a true, correct and complete copy of
which has been Made Available to Buyer, are valid, binding and enforceable in accordance with their
respective terms and shall be in full force and effect without penalty upon consummation of the
transactions contemplated hereby. Except as set forth on Section 3.13 of the Disclosure Schedule,
no Material Contract requires the obtaining of any consent, approval, novation or waiver of any
third party in connection with this Agreement or the consummation of the transactions contemplated
by this Agreement. Each of the Company and its Subsidiaries has performed in all material respects
all obligations required to be performed by it; is not in default or material breach under any
Contract to which the Company or its Subsidiaries is subject and, to the knowledge of the Company,
there is no basis for any such claim; and neither the Company nor any of its Subsidiaries has any
present expectation or intention of not fully performing on a timely basis all such obligations
required to be performed by the Company or any of its Subsidiaries under any contract, agreement or
instrument to which the Company or any of its Subsidiaries is subject; to the Company’s knowledge
no event has occurred which with the passage of time or the giving of notice or both would result
in a default, breach or event of noncompliance by the Company or any of its Subsidiaries under any
contract, agreement or instrument to which the Company or any of its Subsidiaries is subject; and
neither the Company nor any of its Subsidiaries has any knowledge of any breach or cancellation (or intention

-35-

 

to cancel) by the other parties to any contract, agreement, instrument or commitment to which it is
a party. To the Company’s knowledge, neither the Company nor any of its Subsidiaries is a party to
any contract, agreement or commitment the performance of which could reasonably be expected to have
a Company Material Adverse Effect.

     3.14 Interested Party Transactions.  Except as set forth in Section 3.14 of the Disclosure
Schedule, no managing board member, shareholder, employee or Affiliate of the Company (excluding
Subsidiaries) or, to the Company’s knowledge, any individual related by blood, marriage or adoption
to any such individual or any entity in which any such Person or individual owns any beneficial
interest is a party to any agreement, contract (except employment contracts with the Company or its
Subsidiaries), commitment or transaction with the Company or its Subsidiaries or has any interest
in any property used by the Company or its Subsidiaries (including any Intellectual Property
Rights).

     3.15 Compliance With Laws; Permits.  Except as set forth in Section 3.15 of the Disclosure
Schedule:

          (a) The Company and its Subsidiaries have complied and are in compliance, in all material
respects, with all applicable Laws of all Governmental Entities relating to the operation of their
businesses and the maintenance and operation of their properties and assets. No notices have been
received by and no claims have been filed against the Company or any of its Subsidiaries alleging a
violation of any such Laws.

          (b) The Company and its Subsidiaries hold and are in compliance with all Permits of or from
Governmental Entities required for the conduct of their businesses as presently conducted and the
ownership of their properties, and Section 3.15 of the Disclosure Schedule sets forth a list of all
of the Permits that are material to the Company or any of its Subsidiaries or their respective
businesses. No notices have been received by the Company or any of its Subsidiaries alleging the
failure to hold any of the foregoing. All of such Permits will be available for use by the Company
and its Subsidiaries at the Closing.

     3.16 Litigation.  Except as set forth in Section 3.16 of the Disclosure Schedule, there are no
Actions, pending or, to the Company’s knowledge, threatened against the Company or its Subsidiaries
or their respective properties (tangible or intangible) or pending or threatened by the Company or
its Subsidiaries against any Person, before or by any Governmental Entity (including any Actions
with respect to the transactions contemplated by this Agreement); neither the Company nor any of
its Subsidiaries is subject to any arbitration proceedings under collective bargaining agreements
or otherwise or any governmental investigations or inquiries; and, to the Company’s knowledge,
there is no basis for any of the foregoing. Neither the Company nor
any of its Subsidiaries is subject to any judgment, order or decree of any court or other
Governmental Entity, and neither the Company nor its Subsidiaries has received any opinion or
memorandum or advice from legal counsel or compliance personnel to the effect that it is exposed,
from a legal standpoint, to any liability or disadvantage which may be (individually or in the
aggregate) material to their respective businesses or properties.

-36-

 

     3.17 Pensions. 

          (a) Section 3.17(a) of the Disclosure Schedule contains an accurate and complete list, as of
the date hereof, of each Company Employee Plan, whether or not subject to ERISA, and each Employee
Agreement. The Company has provided to Buyer a current, accurate and complete copy (or, to the
extent no such copy exists, an accurate description) of each such Company Employee Plan or Employee
Agreement and all related documents.

          (b) Each employee benefit plan or pension scheme maintained for the benefit of the employees
of the Company or any of its Subsidiaries has to the Company’s knowledge been maintained, funded
and administered in accordance with the terms of such employee benefit plan or pension scheme and
complies in form and in operation in all material respects with the requirements of applicable Law.

          (c) All required reports and descriptions (including annual reports, summary annual reports,
and summary plan descriptions) have been timely filed and/or distributed in accordance with the
requirements of applicable Law with respect to each such employee benefit plan or pension scheme.

          (d) All contributions (including all employer contributions and employee salary reduction
contributions) that are due pursuant to each such employee benefit plan or pension scheme have been
made within the time periods required by such employee benefit plan or pension scheme and
applicable Law and all contributions for any period ending on or before the Closing Date that are
not yet due have been made to each such employee benefit plan or pension scheme or accrued in
accordance with the past custom and practice of the Company and its Subsidiaries.

          (e) No action, suit, proceeding, hearing, or investigation with respect to the administration
or the investment of the assets of any such employee benefit plan or pension scheme (other than
routine claims for benefits) is pending or to the Company’s knowledge threatened.

          (f) Section 3.17(f) of the Disclosure Schedule sets forth a complete list as of the date
hereof, of current Company Employees, consultant, independent contractor, and other contingent
worker used by the Company or any of its Subsidiaries.

          (g) No Company Employee Plan is (i) subject to Title IV of ERISA or Section 412 of the Code,
(ii) a “multiemployer plan” (as defined in Section 3(37) of ERISA) (iii) a ”multiple employer plan”
as defined in ERISA or the Code, or (iv) a “funded welfare plan” within the meaning of Section 419
of the Code. No Company Employee Plan provides health benefits that are not fully insured through
an insurance contract.

          (h) No Company Employee Plan exists that, except as may otherwise be required pursuant to
applicable Law, as a result of the execution of this Agreement, shareholder approval of this
Agreement, or the transactions contemplated by this Agreement (whether alone or in connection with
any subsequent event(s)), could (i) result in severance pay or any increase in severance pay upon
any termination of employment after the date of this Agreement, (ii) accelerate the time of

-37-

 

payment
or vesting or result in any payment or funding (through a grantor trust or otherwise) of
compensation or benefits under, increase the amount payable or result in any other material
obligation pursuant to, any of the Company Share Plans, (iii) limit or restrict the right of the
Company or any of its subsidiaries to merge, amend or terminate any of the Company Share Plans,
(iv) cause the Company or any of its subsidiaries to record additional compensation expense on its
income statement with respect to any outstanding stock option or other equity-based award, or (v)
result in payments under any of the Company Share Plans which would not be deductible under Section
280G of the Code.

          (i) The Company is in good faith compliance with the requirements of Section 409A of the Code
with respect to all “nonqualified deferred compensation plans” (as defined in Section 409A of the
Code) maintained by the Company or any of its Subsidiaries or to which the Company or any of its
Subsidiaries is a party.

     3.18 Employees.  The Company’s knowledge, no key Company Employee or independent contractor of
the Company or any of its Subsidiaries and no group of Company Employees or independent contractors
of the Company or any of its Subsidiaries has any plans to terminate employment with the Company or
any of its Subsidiaries. Neither the Company nor any of its Subsidiaries have any material labor
relations problems (including any union organization activities, threatened or actual strikes or
work stoppages or material grievances). The Company and each of its Subsidiaries have complied in
all material respects with all Laws relating to the employment of labor (including, without
limitation, provisions thereof relating to wages, hours, equal opportunity, collective bargaining
and the payment of social security and other taxes) and have complied with all Laws related to the
licensing of employees under its applicable licenses. Neither the Company, its Subsidiaries nor,
to the Company’s knowledge, any of their employees or independent contractors is subject to any
noncompete or similar agreements in conflict with the present business activities of the Company
and its Subsidiaries, except for agreements between the Company or any of its Subsidiaries and
their respective present and former employees.

     3.19 Insurance.  Section 3.19 of the Disclosure Schedule contains a description, as of the
date hereof, of each insurance policy maintained by the Company or any of its Subsidiaries with
respect to their respective properties, assets and business, and each such policy shall be in full
force and effect up to the Closing. Neither the Company nor any of its Subsidiaries is in default
or breach with respect to its obligations under any insurance policy maintained by it within the
past two (2) years.

     3.20 Books and Records.  The minute books and other books and records of the Company and each of its Subsidiaries,
which have been Made Available to Buyer (the “Books and Records”), are true, correct and complete
in all material respects. At the Closing, the Books and Records will be in the possession of the
Company.

     3.21 Distributors, Resellers, Partners and Representatives. 

          (a) Section 3.21(a) of the Disclosure Schedule sets forth a complete list, as of the date
hereof, of, and indicating aggregate dollar value of payments made by the Company or any of

-38-

 

its
Subsidiaries within each of the most recently completed fiscal year and the current fiscal
year-to-date of the Company or any Subsidiary thereof to, the ten (10) largest distributors or
resellers of the Company Products based on gross revenues from sales of Company Products for the
fiscal year ended December 31, 2006 (the “Top Distributors”). Since December 31, 2006, no Top
Distributor, nor any OEM partner set out in Section 3.21(a) of the Disclosure Schedule (the “OEM
Partners”), materially and adversely modified, or to the knowledge of the Company, threatened to
terminate or materially and adversely modify its relationship with the Company or any Subsidiary
thereof. None of the Company nor any Subsidiary thereof has received any written notice, nor does
the Company have knowledge, that any Top Distributor or OEM Partners intends to terminate or
otherwise materially and adversely modify its relationship with the Company or any Subsidiary
thereof on account of the transactions contemplated by this Agreement or otherwise.

          (b) To the knowledge of the Company, there is no existing material dispute between the Company
or any Subsidiary thereof, on the one hand, and any customer, representative, agent or other
contractor, distributor, reseller, dealer or partner, on the other hand. Other than sales
commissions payable to Company Employees or distributors or resellers of the Company or any of its
subsidiaries in the ordinary course of business, there is no agreement or other arrangement which
would obligate the Company or any Subsidiary thereof to make any payment or pay any commission to
any broker, independent contractor or other Person in connection with the sale of Company Products
or otherwise.

     3.22 Export Control Laws. 

          (a) Except as set forth in Section 3.22(a) of the Disclosure Schedule, the Company has no
reason to believe that either the Company nor any of its Subsidiaries has taken any action with
respect to the Company’s Products, software, or Technology, in violation of, or which may cause the
Seller to be in violation of, any applicable Export Control Laws.

          (b) Except as set forth in Section 3.22(b) of the Disclosure Schedule, there has never been a
claim or charge made, investigation undertaken, violation found, or settlement of any Action under
any Export Control Law, by any Governmental Entity against the Company or any of its Subsidiaries,
with respect to matters arising under such Export Control Laws.

     3.23 Corrupt Practices.  Neither the Company nor its Subsidiaries, on the one hand, nor any of their officers,
directors, employees, stockholders, agents or representatives, or any Person associated with or
acting for or on behalf of the Company or any of its Subsidiaries, on the other hand, have directly
or indirectly (a) made or attempted to make any contribution, gift, bribe, rebate, payoff,
influence payment, kickback, or other payment to any Person, private or public, regardless of what
form, whether in money, property, or services (i) to obtain favorable treatment for business or
Contracts secured, (ii) to pay for favorable treatment for business or Contracts secured, (iii) to
obtain special concessions or for special concessions already obtained, or (iv) in violation of any
requirement of Law, or (b) established or maintained any fund or asset that has not been recorded
in

     3.24 Brokers’ and Finders’ Fees; Third Party Expenses.  Neither the Company nor any of its
Subsidiaries has incurred, or will incur, directly or indirectly, any Liability for brokerage or

-39-

 

finders’ fees or agents’ commissions, fees related to investment banking or similar advisory
services or any similar charges in connection with this Agreement or any transaction contemplated
hereby, nor will Buyer incur, directly or indirectly, any such Liability based on arrangements made
by or on behalf of the Company or any of its Subsidiaries.

ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF THE SELLERS

     Each Seller, severally and not jointly, in respect of such Seller’s own shares of Company
Capital Stock and in such Seller’s capacity as a shareholder of the Company, hereby represents and
warrants to Buyer as of the date hereof and as of the Closing Date as follows:

     4.1 Authority.

          (a) Such Seller has full power and authority, including any necessary spousal consent required
by applicable Law, and legal capacity to execute and deliver this Agreement and any Ancillary
Agreements to which such Seller is a party and to perform his obligations hereunder and thereunder
and to consummate the transactions contemplated hereby and thereby.

          (b) Each of this Agreement and each Ancillary Agreement to which such Seller is a party have
been duly and validly executed and delivered by such Seller and, assuming the due authorization,
execution and delivery hereof and thereof by Buyer and each other counterparty thereto, constitutes
a legal, valid and binding obligation of such Seller, enforceable against such Seller in accordance
with their respective terms.

     4.2 Non-Contravention.  The execution and delivery by such Seller of this Agreement and any
Ancillary Agreement to which such Seller is a party do not, and the performance by such Seller of
its obligations hereunder and thereunder and the consummation by such Seller of the transactions
contemplated hereby and thereby do not and will not conflict with or result in a violation or
breach of any Law or order applicable to, or Contract binding upon, such Seller or any of his
assets and properties.

     4.3 Necessary Approvals. 

          (a) To such Seller’s knowledge, no consents, notices, waivers, approvals, orders,
authorizations, registrations, declarations or filings with any Governmental Entity are required to
be given to, or obtained by, such Seller (each a “Seller Approval”) in connection with the
consummation of the consummation of the Share Purchase or other transactions contemplated by this
Agreement.

          (b) To such Seller’s knowledge, no Seller Approvals are required to be given to, or obtained
by, such Seller or any of its Affiliates (excluding the Company and its Subsidiaries) from any
other Person in connection with the consummation of the Share Purchase or other transactions
contemplated by this Agreement, other than those referred to in Section 3.6 and except for such
Seller Approvals that will be obtained by such Seller prior to or by the Closing and which are
specifically set forth on Section 4.3(b) of the Disclosure Schedule.

-40-

 

     4.4 Legal Ownership of Shares. Such Seller is the sole record and beneficial owner of the
Shares set forth opposite such Seller’s name on Exhibit A, free and clear of all Liens. No
third party has a beneficial interest in or a right to acquire or vote any such Shares. Such
Seller has the full power and authority to vote, the number of such Shares, free and clear of any
Liens and any preemptive rights, rights of first refusal, options or other voting, purchase or sale
rights that have not been heretofore waived. Such Seller is the sole record and beneficial owner
of the Company Options and Depository Receipts set forth opposite such Seller’s name on Exhibit
A (the “Owned Options” and “Owned Depository Receipts”), free and clear of any Liens and any
preemptive rights, rights of first refusal, options or other voting, purchase or sale rights that
have not been heretofore waived, except as may exist pursuant to the Company Share Plans. Such
Shares, Owned Options and Owned Depository Receipts constitute all of the Company Shares, Company
Options and Depository Receipts owned of record or beneficially by such Seller. Except as
applicable in connection with this Agreement and the transactions contemplated hereby, such
Seller’s Shares will be at all times from the date of this Agreement until the earlier of the
termination of this Agreement in accordance with Article X hereof or the Closing beneficially owned
and held of record by such Seller, free and clear of any and all Liens and any preemptive rights,
rights of first refusal, options or other voting, purchase or sale rights that have not been
heretofore waived.

     4.5 Domicile of Sellers. Section 4.5 of the Disclosure Schedule sets forth the true and
correct current residence address and country of Tax residence of such Seller.

ARTICLE V

REPRESENTATIONS AND WARRANTIES OF BUYER

     Buyer hereby represents and warrants to the Sellers as follows:

     5.1 Organization and Qualification. Buyer is a corporation duly organized and validly
existing under the laws of the Republic of Malta. Buyer has all necessary corporate power and
authority to own its properties and to carry on its business as now conducted and as currently
contemplated to be conducted.

     5.2 Authority. Buyer has all requisite corporate power and authority to enter into this
Agreement and the Ancillary Agreements to which it is a party and, subject to satisfaction of the
conditions set forth herein, to consummate the transactions contemplated hereby and thereby. The
execution and delivery of this Agreement and the consummation of the transactions contemplated
hereby and thereby have been duly authorized by all necessary corporate action on the part of
Buyer, and no further action is required on the part of Buyer or its stockholders to authorize the
Agreement and the transactions contemplated hereby. This Agreement has been, and upon their
execution by the appropriate parties thereto the Ancillary Agreements will be, duly executed and
delivered by Buyer and this Agreement constitutes, and upon their execution the Ancillary
Agreements will constitute, legal valid and binding obligations of Buyer enforceable against Buyer
in accordance with their respective terms, subject to the effect of applicable bankruptcy,
insolvency, reorganization

-41-

 

or other similar Laws affecting the rights of creditors and the effect
or availability of rules of Law governing specific performance, injunctive relief or other
equitable remedies.

     5.3 No Breach. The execution and delivery by Buyer of this Agreement and any Ancillary
Agreement to which Buyer is a party do not, and the performance by Buyer of its obligations
hereunder and thereunder and the consummation by Buyer of the transactions contemplated hereby and
thereby do not and will not conflict with or result in a violation or breach of Buyer’s Governing
Documents or any Law or Order applicable to, or Contract or any Permit of or binding upon, Buyer or
any of its assets and properties.

     5.4 Litigation. There are no actions, suits, proceedings (including any administrative, self
regulatory organization or arbitration proceedings), orders or claims pending or, to Buyer’s
knowledge, threatened against Buyer or its Subsidiaries, or pending or threatened by the Company or
its Subsidiaries against any Person, before or by any Governmental Entity with respect to the
transactions contemplated by this Agreement.

     5.5 Financial Means. Buyer has or will have at Closing sufficient cash resources to pay the
Purchase Price.

ARTICLE VI

CONDUCT PRIOR TO THE CLOSING DATE

     6.1 Conduct of Business of the Company. During the period from the date of this Agreement
and continuing until the earlier of the termination of this Agreement in accordance with Article X
hereof or the Closing Date, the Company agrees to, and the Sellers agree to cause the Company to,
operate the business of the Company and to cause its Subsidiaries to conduct their respective
businesses, except (x) as specifically disclosed in Section 6.1 of the Disclosure Schedule, (y)
with the prior written consent of Buyer or (z) as specifically permitted by this Agreement, in
accordance with applicable Law and in the ordinary course consistent with past practices. In
furtherance of the foregoing, the Company agrees to pay and to cause its Subsidiaries to pay all
Indebtedness and Taxes of the Company and its Subsidiaries when due (subject to good faith disputes
with respect to such Taxes pursuant to appropriate proceedings and for which adequate reserves have
been established). Without limiting the generality of the foregoing, except (i) as expressly
permitted by this Agreement, (ii) as expressly set forth in Section 6.1 of the Disclosure Schedule,
or (iii) with the prior written consent of Buyer, neither the Company nor any of its Subsidiaries
shall, and the Sellers agree to cause the Company and its Subsidiaries not to, from and after the
date of this Agreement and continuing until the earlier of the termination of this Agreement in
accordance with Article X hereof or the Closing Date:

          (a) issue, grant, deliver or sell or authorize or propose the issuance, grant, delivery or
sale of, or purchase or propose the purchase of, any shares of Company Capital Stock or shares of
any capital stock of any Subsidiary of the Company or any securities convertible into, or
subscriptions, rights, warrants or options to acquire, or other agreements or commitments of any
character obligating it to issue or purchase any such shares or other convertible securities, other
than (i) issuances of Company Capital Stock pursuant to exercises of Company Options or warrants to

-42-

 

purchase Company Capital Stock in accordance with their terms, and (ii) repurchases at cost of
Company Ordinary Shares upon termination of a service provided and pursuant to the terms of a
Contract existing on the date hereof and listed on the Disclosure Schedule;

          (b) incur any Indebtedness or guarantee any Indebtedness for borrowed money or issue or sell
any debt securities or guarantee any debt securities or other obligations of others or create a
Lien over any of its assets;

          (c) pay, discharge or satisfy, in an amount in excess of €50,000 in any one case, or €150,000
in the aggregate, any claim, Liability, loan or obligation (absolute, accrued, asserted or
unasserted, contingent or otherwise), other than the payment, discharge or satisfaction in the
ordinary course of business of Liabilities (other than Indebtedness) reflected or reserved against
in the Company Balance Sheet;

          (d) declare, set aside, or pay any dividends on or make any other distributions (whether in
cash, stock or property) in respect of any Company Capital Stock or any capital stock of any
Subsidiary of the Company, or split, combine or reclassify any Company Capital Stock or any capital
stock of any Subsidiary of the Company or issue or authorize the issuance of any other
securities in respect of, in lieu of or in substitution for shares of Company Capital Stock or
shares of any capital stock of any Subsidiary of the Company, or repurchase, redeem or otherwise
acquire, directly or indirectly, any shares of Company Capital Stock or shares of any capital stock
of any Subsidiary of the Company (or options, warrants or other rights exercisable therefor),
except in accordance with the agreements evidencing Company Options;

          (e) sell, assign, lease, license or otherwise transfer any of its tangible assets, except (i)
in the ordinary course of business consistent with past practice, or (ii) not otherwise exceeding
€20,000 in the aggregate.

          (f) initiate, compromise or settle any Action or cancel, compromise, waive, or release any
right or claim in excess of €100,000 or that would otherwise be material to the Company or any of
its Subsidiaries;

          (g) (i) transfer ownership of or exclusively license any Company Intellectual Property or
execute any Contract for the transfer of ownership or the exclusive license of any Company
Intellectual Property to any Person, or (ii) non-exclusively license any Company Intellectual
Property or enter into any Contract for the non-exclusive license of any Company Intellectual
Property to any person, other than non-exclusive licenses entered into in the ordinary course of
business consistent with past practices;

          (h) grant any severance or termination pay (in cash or otherwise) to any Company Employee,
including any officer of the Company or any of its Subsidiaries, except payments made pursuant to
(x) the Company Employee Plans set forth in the Disclosure Schedule and Made Available to Buyer,
(y) standard written Contracts outstanding on the date hereof and disclosed in the Disclosure
Schedule and Made Available to Buyer, or (z) applicable foreign Laws;

-43-

 

          (i) hire or offer to hire (other than non-executive employees in the ordinary course of
business consistent with past practices, provided that “non-executive employees” for this purpose
means those employees below the vice president level) or terminate any Company Employees (other
than non-executive and non-developer employees in the ordinary course of business for cause), or
intentionally encourage any Company Employees to resign from the Company or any of its
Subsidiaries;

          (j) adopt, amend or fail to maintain any Company Employee Plan, enter into any employment
contract, pay or agree to pay any special bonus or special remuneration to any director or Company
Employee, or increase or agree to increase the salaries, wage rates, or other compensation or
benefits of any Company Employee except payments made pursuant to this Agreement or standard
written agreements outstanding on the date hereof and disclosed in the Disclosure Schedule;

          (k) make any material capital expenditures or commitments therefore or engage in or enter into
any material transaction or commitment, or relinquish any material right, outside the ordinary
course of the Company’s business consistent with past practice;

          (l) grant any loans or advances to, guarantees for the benefit of, or any investments in any
Person (including incorporation of Subsidiaries), other than advances in the ordinary course of
business consistent with past practice;

          (m) make any change in any method of accounting or accounting policies or procedures,
including with respect to reserves for excess or obsolete inventory, doubtful accounts or other
reserves, depreciation or amortization policies or rates, billing and invoicing policies, or
payment or collection policies or practices, except insofar as may have been required by IFRS or
required to change any assumption underlying, or method of calculating, any bad debt, contingency
or other reserve or revalue any of the assets (whether tangible or intangible) of the Company or
any of its Subsidiaries;

          (n) enter into or renew or extend any Contracts or arrangements that materially limit or
restrict the Company or any of its Subsidiaries, or that could, after the Closing, materially limit
or restrict Buyer or any of its Affiliates, from engaging or competing in any line of business or
in any geographic area or that involve exclusive or most-favored-nations terms of any kind

          (o) acquire or agree to acquire by merging or consolidating with, or by purchasing any assets
or equity securities of, or by any other manner, any business or any Entity or division thereof, or
otherwise acquire or agree to acquire any assets which are material, individually or in the
aggregate, to the Company’s business or any of its Subsidiaries’ businesses;

          (p) terminate or extend, or materially amend, waive, modify, or violate the terms of, any
Material Contract (or agree to do so), or enter into any Contract which would have been required to
have been disclosed in Section 3.13 of the Disclosure Schedule had such Contract been entered into
prior to the date hereof;

-44-

 

          (q) enter into or materially amend, waive or modify the terms of any license or any
distribution, joint venture, strategic alliance, outbound OEM, or joint marketing or any similar
Contract or arrangement or any Contract pursuant to which any other party is granted marketing,
distribution, resale, development or similar rights of any type or scope with respect to any
Company Products or Technology of the Company or any of its Subsidiaries, other than in the
ordinary course of the Company’s business consistent with past practice or non-exclusive licenses
of the Company Products to end-users pursuant to Contracts that have been entered into in the
ordinary course of business consistent with past practices that do not materially differ in
substance from the Standard Form Agreements;

          (r) cause or permit any amendments to its Governing Documents, or to the Governing Documents
of any of its Subsidiaries;

          (s) take any action to accelerate or discount any accounts receivable, defer, delay or
postpone beyond the time allotted for payment any accounts payable or any other obligation of the
Company or any of its Subsidiaries, or deviate from the Company’s historical practices in the
ordinary course of business with respect to the use of any promotional sales or discount activity;

          (t) make or change any material Tax election, adopt or change any Tax accounting method
(including depreciation rates and valuation methods), enter into any closing agreement or Tax
ruling, settle or compromise any material Tax claim or assessment, consent to any extension or
waiver of the limitation period applicable to any material Tax claim or assessment, or file any
income or other material Tax Return or any amended Tax Return unless such Tax Return has been
provided to Buyer for review prior to such filing; or

          (u) take, commit or agree in writing or otherwise to take, any of the actions described in
Sections 6.1(a) through 6.1(t), inclusive.

     6.2 Procedures for Requesting Buyer Consent. If the Company desires to take an action which
would be prohibited pursuant to Section 6.1 hereof without the written consent of Buyer, prior to
taking such action the Company may request such written consent by sending an e-mail or facsimile
to each of the following individuals:

Ken Gonzalez

Telephone: (408) 346-3150

Facsimile: (408) 346-3314

E-mail address: ken_gonzalez@mcafee.com

Jared Ross

Telephone: (972) 963-7944

Facsimile: (972) 963-7425

E-mail address: jared_ross@mcafee.com

-45-

 

     Any of the parties set forth above may grant consent on behalf of Buyer to the taking of any
action which would otherwise be prohibited pursuant to Section 6.1 by e-mail or such other notice
that complies with the provisions of Section 12.3.

     6.3 No Solicitation.

          (a) Until the earlier of (i) the Closing Date, or (ii) the date of termination of this
Agreement pursuant to the provisions of Article X hereof, none of the Sellers, the Company or any
of its Subsidiaries shall, and the Company and each Seller shall cause their Representatives not
to, directly or indirectly, take any of the following actions with any party other than Buyer and
its designees: (A) solicit, initiate, participate in or encourage any negotiations or discussions
with respect to any offer or proposal to acquire all or any material portion of the business,
properties or technologies of the Company or any of its Subsidiaries, or any amount of the Company
Capital Stock (whether or not outstanding) that is greater than five percent (5%), whether by
merger, purchase of assets, purchase or issuance of shares or rights to acquire shares, tender
offer, or otherwise (a “Competing Transaction”), or effect any such transaction, (B) disclose any
information to any Person concerning the business, technologies or properties of the Company or
any of its Subsidiaries, or afford to any Person access to the Company’s properties,
technologies, books or records in connection with a Competing Transaction; (C) assist or cooperate
with any Person to make any proposal regarding a Competing Transaction, or (D) enter into any
agreement with any Person providing for a Competing Transaction. In the event that the Company or
any Seller or any of their Representatives has received or becomes aware of, prior to the Closing
Date or the termination of this Agreement in accordance with Article X hereof, any offer, proposal,
or request, directly or indirectly, of the type referenced in clause (A), (B) or (C) above, the
Company shall immediately (x) suspend any discussions with such offeror or party with regard to
such offers, proposals, or requests and (y) notify Buyer thereof, including information as to the
identity of the offeror or the party making any such offer or proposal and the specific terms of
such offer or proposal, as the case may be, and such other information related thereto as Buyer may
reasonably request.

          (b) The Parties hereto agree that irreparable harm would occur in the event that the
provisions of this Section 6.3 were not performed in accordance with their specific terms or were
otherwise breached. It is accordingly agreed by the Parties hereto that Buyer shall be entitled to
an immediate injunction or injunctions, without the necessity of proving the inadequacy of money
damages as a remedy and without the necessity of posting any bond or other security, to prevent
breaches of the provisions of this Section 6.3 and to enforce specifically the terms and provisions
hereof in any United States (federal or state) or foreign court having jurisdiction, this being in
addition to any other remedy to which Buyer may be entitled at law or in equity. Without limiting
the foregoing, it is understood that any violation of the restrictions set forth above by any
Representative of the Company or any Seller shall be deemed to be a breach of this Agreement by the
Company or such Seller.

     6.4 Covenant Not To Transfer. Until the earlier of (i) the Closing Date, or (ii) the date of
termination of this Agreement pursuant to the provisions of Article X hereof, each Seller agrees

-46-

 

not to, directly or indirectly, without the prior written consent of Buyer: (a) offer for sale,
sell, transfer, tender, pledge, hypothecate, assign or otherwise dispose of, grant or enter into
any Contract, option, commitment or other arrangement or understanding with respect to or consent
to the offer for sale, sale, transfer, tender, pledge, hypothecation, assignment or other
disposition of, any or all of the Shares, Company Options or Depository Receipts (or any interest
therein) (each, a “Transfer”); provided, however, that the foregoing restrictions shall not apply
to any Transfer of any Shares by any Seller pursuant to any bona fide gift of Shares effected for
tax planning purposes (a “Permitted Transfer”); provided, however, that prior to or concurrently
with such Permitted Transfer the transferee or other recipient thereof executes a counterpart copy
of this Agreement and becomes bound hereby to the same extent as the Seller; (b) except as
contemplated by this Agreement, grant any proxies or powers of attorney, deposit any Shares,
Company Options or Depository Receipts into a voting trust or enter into a voting agreement with
respect to any Shares, Company Options or Depository Receipts; or (c) take any action or omit to
take any action that would prohibit, prevent or preclude the Seller from performing such Seller’s
or the Company’s obligations under this Agreement.

ARTICLE VII

ADDITIONAL AGREEMENTS

     7.1 Access to Information. To the extent not prohibited by applicable Law, during the period
from the date hereof and prior to the Closing Date, the Company shall (a) upon reasonable prior
notice, afford Buyer and its Representatives, reasonable access during normal business hours to all
of the properties, Books and Records, Contracts, commitments, other records and Company Employees
of the Company and its Subsidiaries as Buyer and its accountants, counsel and other representatives
may reasonably request, provided that such access does not unreasonably interfere with the business
of the Company and provided further that Buyer will bear its own costs and any out-of-pocket costs
of the Company, other than wages and salaries and employee benefits of relevant personnel, of
obtaining such access, and (b) promptly upon request make available to Buyer and its accountants,
counsel and other representatives copies of internal financial statements (including Tax Returns
and supporting documentation) as Buyer may from time to time reasonably request. No information or
knowledge obtained in any investigation pursuant to this Section 7.1 or otherwise shall affect or
be deemed to modify any representation or warranty contained herein or the conditions to the
obligations of the Parties to consummate the Share Purchase in accordance with the terms and
provisions hereof.

     7.2 Public Disclosure. Neither the Company nor any of the Sellers shall (and they will use
reasonable best efforts to cause their respective Representatives not to), directly or indirectly,
issue any statement or communication to any third party (other than its Representatives that are
bound by confidentiality restrictions) regarding the subject matter of this Agreement or the
transactions contemplated hereby, including, if applicable, the termination of this Agreement and
the reasons therefor, without the consent of Buyer, except that this restriction shall be subject
to (a) any Seller’s right after the Closing to provide information about the subject matter of this
Agreement and the transactions contemplated hereby in connection with such Seller’s or its
Affiliates’ fund raising, marketing, information and reporting activities, and (b) each of the
Sellers’ and the Company’s

-47-

 

obligations to comply with applicable law. Buyer shall not (and will
use reasonable best efforts to cause its Representatives not to), directly or indirectly, prior to
the Closing Date, issue any statement or communication to any third party (other than its
Representatives that are bound by confidentiality restrictions) regarding the subject matter of
this Agreement or the transactions contemplated hereby, including, if applicable, the termination
of this Agreement and the reasons therefor, without the consent of the Company, except that this
restriction shall be subject to (a) Buyer’s obligation to comply with applicable securities laws
and the rules of the New York Stock Exchange, and (b) Buyer’s obligations to comply with applicable
Law. Notwithstanding the foregoing, this Section 7.2 shall not prevent Buyer from issuing any
statement or communication that is reasonably necessary in response to a public statement or
announcement made by any Person with respect to the transactions contemplated by this Agreement.

     7.3 Employee Matters.

          (a) As may be specifically directed by Buyer in writing, the Company shall, prior to the
Closing, cause each officer, each specified member of the Supervisory Board of the Company and/or
the Management Board of the Company and each of its Subsidiaries to execute a resignation letter
and general release in form and substance satisfactory to Buyer (each, a “Director Resignation
Letter”), effective as of the Closing. In connection with the foregoing, the Company shall cause
that certain Supervisory Board Member Agreement with Mr. John Michael Crowther dated as of
September 28, 2007 (and any other similar agreements) to be terminated without any obligation on
the part of the Company or any of its Subsidiaries, effective as of the Closing.

          (b) Buyer shall, or cause its Affiliates to, offer to hire, as of 12:01 a.m. on the day
immediately following the Closing Date, the Company Employees based outside of the United States
listed on Schedule 7.3(b) of this Agreement (the “Company Foreign Employees”), in
accordance with the Foreign Employee Transfer Regulations and any other applicable Law. The
Sellers, the Company, its Subsidiaries and Buyer will cooperate to provide Buyer with reasonable
access to such employees prior to the Closing Date and to provide any required notices and
consultation to Company Foreign Employees in accordance with the Foreign Employee Transfer
Regulations. Buyer will satisfy applicable Law with respect to the employment of each Company
Foreign Employee, including the Foreign Employee Transfer Regulations. The Company and its
Subsidiaries, and each Seller, will use commercially reasonable efforts to ensure that each Company
Foreign Employee will consent to the transfer of his or her employment relationship to, or accept
an offer of employment from, Buyer. Buyer will assume and discharge timely and fully all
obligations and liabilities arising under the Foreign Employee Transfer Regulations that become due
to any Company Foreign Employee on or after the Closing Date including any obligations and
liabilities in connection with any change in the terms and conditions of such Company Foreign
Employee’s employment with Buyer from the terms and conditions of such individual’s employment with
Company or its Subsidiaries, as applicable, as of the Closing Date.

     7.4 Section 280G Payments. If and to the extent necessary, as soon as reasonably practicable
after the execution of this Agreement, the Company shall submit to its shareholders for approval
(in a manner satisfactory to Buyer), by such number of Company shareholders as is

-48-

 

required by the
terms of Section 280G(b)(5)(B) of the Code, any Section 280G Payments (which initial determination
shall be made by the Company and shall be subject to review and approval by Buyer), such that such
Section 280G Payments shall not be deemed to be Section 280G Payments, and prior to the Closing,
the Company shall deliver to Buyer evidence satisfactory to Buyer that (a) a Company shareholder
vote was solicited in conformance with Section 280G of the Code and the regulations promulgated
thereunder and the requisite Company shareholder approval was obtained with respect to any Section
280G Payments that were subject to the Company shareholder vote, or (b) that the Company
shareholder approval of Section 280G Payments was not obtained and as a consequence, that such
payments and/or benefits shall not be made or provided to the extent they would cause any amounts
to
constitute Section 280G Payments, pursuant to the waivers of those payments and/or benefits,
which were executed by the affected individuals prior to the Company shareholder vote.

     7.5 Regulatory Filings; Reasonable Efforts.

          (a) As promptly as practicable, each of Buyer, the Company and the Sellers shall, as
applicable, make (or cause to be made) all filings, notices, petitions, statements, registrations,
submissions of information, application or submission of other documents required by any
Governmental Entity in connection with the transactions contemplated hereby, including (i)
notification and report forms with the United States Federal Trade Commission and the Antitrust
Division of the United States Department of Justice as required by the HSR Act, and (ii) any other
filings necessary to satisfy Section 8.1(d). Each of the Parties hereto will cause all documents
that it is responsible for filing with any Governmental Entity pursuant to this Section 7.5(a) to
comply in all material respects with all applicable Laws and will promptly supply the other with
any information that may reasonably be required in order to effectuate any such filings or any
amendment or supplement thereto.

          (b) Each of Buyer, the Company and the Sellers shall use reasonable best efforts to take, or
cause to be taken, all actions, and to do, or cause to be done, and to assist and cooperate with
the other parties in doing, all things reasonably necessary, proper or advisable to consummate and
make effective, in the most expeditious manner practicable, the transactions contemplated by this
Agreement, including using its or his reasonable best efforts to accomplish the following: (i) the
taking of all acts reasonably necessary to cause the conditions precedent set forth in Article VIII
to be satisfied, (ii) the obtaining of all necessary actions or nonactions, waivers, consents,
approvals, orders and authorizations from Governmental Entities and the making of all necessary
registrations, declarations and filings and the taking of all reasonable steps as may be necessary
to avoid any Action by any Governmental Entity, (iii) the obtaining of necessary Consents from
third parties, and (iv) the defending of any Actions challenging this Agreement or the consummation
of the transactions contemplated hereby; provided, however, that, notwithstanding anything to the
contrary contained in this Agreement, (a) neither Parent nor any of its Subsidiaries shall be
required to agree to any license, sale or other disposition or holding separate (through
establishment of a trust or otherwise) of any shares of its capital stock or of any of its
businesses, assets or properties, its Subsidiaries or Affiliates (other than with respect to assets
or properties that are immaterial to Parent and its businesses, which shall not include any product
sold by Parent or any of its Subsidiaries or

-49-

 

any component product thereof), (b) neither Parent nor
the Company shall be required to agree to the imposition of any material limitation on the ability
of Parent, its Subsidiaries or Affiliates or the Company to conduct their respective businesses or
own any capital stock or assets or to acquire, hold or exercise full rights of ownership of their
respective businesses and, in the case of Buyer, the businesses of the Company or its Subsidiaries,
or (c) neither Parent nor the Company, nor any of their respective Subsidiaries shall be required
to take any action that would materially and adversely affect the benefits expected to be derived
by Parent from the Share Purchase.

          (c) Each of Buyer, the Company and the Sellers will notify the other promptly upon the receipt
of (i) any comments from any officials of any Governmental Entity in connection with any filings
made pursuant hereto, (ii) any request by any officials of any Governmental Entity for amendments
or supplements to any filings made pursuant to, or information provided to comply in all material
respects with, any Law, (iii) any Action pending or, to its knowledge, Threatened against such
party hereto that challenges the transactions contemplated by this Agreement and (iv) any notice or
other communication from any Person alleging that the Consent of such Person is or may be required
in connection with the transactions contemplated by this Agreement.

     7.6 Notification of Certain Matters. The Company, the Sellers, or Buyer, as the case may be,
shall promptly (but in any event within two (2) Business Days), upon becoming aware, give notice to
the other parties of: (a) the occurrence of any event that causes any representation or warranty of
the Company, the Sellers or Buyer, respectively and as the case may be, contained in this Agreement
to be untrue or inaccurate at or prior to the Closing Date, and (b) any failure of the Company, the
Sellers or Buyer, as the case may be, to comply with or satisfy any covenant, condition or
agreement to be complied with or satisfied by it hereunder; provided, however, that the delivery of
any notice pursuant to this Section 7.6 shall not limit or otherwise affect any remedies available
to the party receiving such notice. No disclosure by the Company, the Sellers or Buyer pursuant to
this Section 7.6, however, shall be deemed to amend or supplement the Disclosure Schedule or
prevent or cure any misrepresentations, breach of warranty or breach of covenant.

     7.7 Consents. The Company shall use reasonable best efforts to obtain all necessary consents,
waivers and approvals of any parties to any Contract as are required thereunder in connection with
the Share Purchase or for any such Contracts to remain in full force and effect, provided that the
Company and its Subsidiaries shall not be obligated to agree to any adverse modification or
amendment to any such Contract, to offer or grant any other adverse accommodation (financial or
otherwise), to commence any litigation or arbitration proceeding or to make any payments (other
than the incurrence of reasonable expenses in connection therewith) in order to obtain any such
consents, waivers and approvals. Such consents, waivers and approvals shall be in a form
reasonably acceptable to Buyer. The Company shall cause to be sent or given all notices to be
required to be sent or given to any parties to any Contract as are required thereunder in
connection with the Share Purchase.

     7.8 Further Assurances. At any time or from time to time after the Closing, at Buyer’s
request, at no cost to Buyer and without further consideration, the Company and each of the Sellers
shall execute and deliver (or cause to be executed and delivered) to Buyer such other instruments
of

-50-

 

sale, transfer, conveyance, assignment and confirmation, provide such materials and information
and take such other actions as Buyer may reasonably deem necessary or desirable in order to more
effectively transfer, convey and assign to Buyer, and to confirm Buyer’s title to, all of the
Shares and to assist Buyer in exercising all
rights with respect thereto, and otherwise to cause the Company and each of the Sellers to
fulfill their respective obligations under this Agreement.

     7.9 New Employee Benefits. As of the Effective Time, Buyer shall provide the Company
Employees who are employed by Buyer or its Subsidiaries (including the Company and its
Subsidiaries) after the Effective Time (the “Continuing Employees”) with substantially the same
benefits in the aggregate as those provided to similarly situated employees of Buyer. For purposes
of determining eligibility to participate, vesting and entitlement to benefits where length of
service is relevant (including for purposes of vacation accrual) under any Buyer employee benefit
plan (other than a defined benefit plan or sabbatical arrangement) and to the extent permitted by
applicable law, Buyer shall provide that the Continuing Employees shall receive service credit
under each Buyer employee benefit plan (other than a defined benefit plan or sabbatical
arrangement) for their period of service with the Company and its Subsidiaries and predecessors
prior to the Closing, except where doing so would cause a duplication of benefits. Nothing in this
Agreement, including this Section 7.9, express or implied, is intended to confer upon any current
or former Company Employee any rights or remedies by reason of this Agreement.

     7.10 Tax Matters. Buyer shall bear, and to the extent permitted by Law, shall pay, any and
all VAT sales, use, transfer (including real property transfer), documentary, stamp, stamp duty,
goods and services, excise, recording and similar Taxes (including any penalties and interest)
incurred in connection with the Share Purchase and the transactions contemplated by this Agreement,
as well as any notarial or other similar fees incurred by the Sellers or Buyer in connection with
this Agreement and the transactions contemplated hereby (“Transfer Taxes”).

     7.11 Waiver of Certain Rights. Each Seller hereby waives any first refusal or similar rights,
to the extent such Seller is entitled to such rights (including, for the avoidance of doubt, any
rights that a holder of Company Preference Shares has to cause the Company to redeem such shares),
in respect of the transfer of the Shares to Buyer and the transactions contemplated hereunder.

     7.12 Release of Claims. Each Seller, effective upon the Closing, on behalf of such
Seller and each of such Seller’s successors and assigns (collectively, the “Releasor Parties”) and
in such Seller’s capacity as a present or former shareholder or optionholder of the Company,
effective as of the Closing, does hereby unconditionally, irrevocably and absolutely release and
forever discharge the Company and each of its Subsidiaries and their respective predecessors,
successors, joint ventures, assigns, past and present members, shareholders, directors, managers,
officers, employees, Affiliates and
Representatives, in their capacities as such (collectively the “Released Parties”), from any
and all loss, liability, obligations, claims, costs, demands, actions, causes of action, suits,
debts, accounts, covenants, Contracts, controversies, damages and judgments of every kind, nature
and character (including, without limitation, claims for damages, costs, expenses and attorneys’,
brokers’ and accountants’ fees and expenses), in each case arising from Releasor Party’s status as
a past or

-51-

 

present shareholder or optionholder of the Company (including, without limitation, any
employment, member or fiduciary duty claims against the Company or its Subsidiaries) in connection
with any transaction, affair or occurrence, whether in law, equity or otherwise, whether known or
unknown, suspected or unsuspected, that Releasor Party now has, has ever had or at any time could
have asserted against any of the Released Parties arising from such matters (collectively, the
"Released Claims”). Notwithstanding anything to the contrary contained herein, this Release shall
not operate to discharge or release the Released Parties from, and the Released Claims shall in no
event include (a) any rights or claims any of the Releasor Parties may have under this Agreement or
any of the Ancillary Agreements, or (b) any rights or claims that a Releasor Party may have against
any Released Party in any capacity other than as specified in the first sentence of this paragraph
(including under any Contract such party may have with any Released Party in such other capacity,
any claims in such party’s capacity as an employee of the Company or any of its Subsidiaries and
any rights to indemnification as a director or officer of the Company or any of its Subsidiaries).
Each such Releasor Party hereby irrevocably agrees, effective as of the Closing Date, to refrain
from, directly or indirectly, asserting any claim or demand or commencing (or allowing to be
commenced on such Releasor Party’s behalf) any suit, action or proceeding of any kind, in any
agency, court or before any tribunal, against any Released Party based upon any Released Claim, it
being the intent by such Releasor Party that with the execution by Releasor Party of this
Agreement, the Released Parties will be absolutely, unconditionally and forever discharged of and
from any and all obligations related in any way to the Released Claims.

     7.13 Confidentiality Obligations.

          (a) The terms and conditions of this Agreement and any other Ancillary Agreements shall be
considered confidential information subject to the confidentiality obligations of Buyer and Seller,
as set forth in the Mutual Nondisclosure Agreement dated December 1, 2006 between Buyer and the
Company (the “Confidentiality Agreement”).

          (b) In addition, each of the Sellers recognize that by reason of such Seller’s ownership of
Company Capital Stock prior to the Closing and information provided by Buyer to the Company and the
Sellers in connection with the Share Purchase, the Sellers have acquired and will acquire
Confidential Information (as defined below), the use or disclosure of which could cause Buyer or
its Affiliates substantial loss and damages that could not be readily calculated and for which no
remedy at law would be adequate. Accordingly, each Seller covenants and agrees and shall cause its
Affiliates to covenant and agree with Buyer that such Seller and its Affiliates will not at any
time, except in performance of its obligations to Buyer, directly or indirectly, use, disclose or
publish, or permit other Persons (including Affiliates and Subsidiaries of such Seller) to disclose
or
publish, any Confidential Information, or use any such information in a manner detrimental to
the interests of Buyer or any of its Affiliates, unless (i) such information becomes generally
known to the public through no fault of such Seller or its Affiliates, (ii) the disclosing party is
advised in writing by counsel that disclosure is required by applicable Law or the order of any
Governmental Entity of competent jurisdiction under color of applicable Law, or (iii) the
disclosing party reasonably believes that such disclosure is required in connection with the
defense of a lawsuit against the disclosing party; provided, that prior to disclosing any
information pursuant to clause (i),

-52-

 

(ii) or (iii) above, such Person shall give prior written
notice thereof to Buyer and provide Buyer with the opportunity to contest such disclosure and shall
cooperate with Buyer’s efforts to prevent such disclosure.

          (c) The term “Confidential Information” includes information that has not been disclosed to
the public or to the trade with respect to Buyer’s or the Company’s present or future business,
operations, services, products, research, inventions, discoveries, drawings, designs, plans,
processes, models, technical information, facilities, methods, trade secrets, copyrights, software,
source code, systems, patents, procedures, manuals, specifications, any other intellectual
property, confidential reports, price lists, pricing formulas, customer lists, financial
information (including the revenues, costs, or profits associated with any of Buyer’s or the
Company’s products or services), business plans, lease structure, projections, prospects,
opportunities or strategies, acquisitions or mergers, advertising or promotions, personnel matters,
legal matters, any other confidential and proprietary information, and any other information not
generally known outside Buyer or the Company that may be of value to Buyer or the Company but
excludes any information already properly in the public domain. “Confidential Information” also
includes confidential and proprietary information and trade secrets that third parties entrust to
Buyer or the Company in confidence.

     7.14 Non-Competition; Non-Solicitation.

          (a) For a period of three (3) years from the Closing Date, none of CBB, Mr. Paul Grootaers or
Mr. Gerhard Watzinger (the “Identified Sellers”) nor any of their respective Subsidiaries or
Affiliates shall anywhere in the Territories, directly or indirectly, for such Identified Seller or
Subsidiary or Affiliate or on behalf of or in conjunction with any other Person, engage, as an
officer, director, manager, member, trustee, stockholder, beneficiary, owner, partner, joint
venture, investor, employee, independent contractor, agent, consultant, advisor, representative or
otherwise, in any business, or in developing, selling, manufacturing, distributing or marketing any
product or service, that competes directly or indirectly, or is reasonably likely to compete
directly or indirectly, with the business of the Company as of the date of this Agreement;
provided, however that each Identified Seller or its Subsidiaries may purchase or otherwise acquire
up to five percent (5%) (in the aggregate) of any class of the securities of any Person (but may
not otherwise participate in the activities of such Person) engaged in the Company’s business if
such securities are listed on any national or regional securities exchange or have been registered
under Section 12(g) of the U.S. Securities Exchange Act of 1934, as amended.

          (b) For a period of two (2) years from the Closing Date, none of the Identified Sellers nor
Summit Partners III S.a.r.l. nor any of their respective Subsidiaries or Affiliates (excluding any
portfolio companies of Summit Partners III S.a.r.l. or any of its affiliated management entities or
investment funds) shall, directly or indirectly, for such Identified Seller or Subsidiary or
Affiliate or on behalf of or in conjunction with any other Person, employ or solicit, or receive or
accept the performance of services by, any Continuing Employee; provided, however, that the
foregoing shall not apply (i) to responses to or follow-up hiring in respect of general
solicitations or advertisements for job positions not specifically directed to Continuing Employees
or (ii) to any Continuing Employee who is terminated by Buyer or any of its Subsidiaries after the
Closing Date or terminates

-53-

 

his or her employment with Buyer without any solicitation directly or
indirectly from the Identified Seller or any of its Subsidiaries or Affiliates.

          (c) The parties agree that the foregoing covenants in this Section 7.14 impose a reasonable
restraint on the Identified Sellers in light of the activities and operations of the Company and
its Subsidiaries on the date of the execution of this Agreement and the current plans of Buyer and
its Affiliates; but it is also the intent of the parties that such covenants be construed and
enforced in accordance with the changing activities and business of Buyer and its Affiliates
(including the Company after the Closing), throughout the term of this covenant.

          (d) If any provision contained in this Section 7.14 shall for any reason be held invalid,
illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not
affect any other provisions of this Section 7.14, but this Section 7.14 shall be construed as if
such invalid, illegal or unenforceable provision had never been contained herein. It is the
intention of the parties that if any of the restrictions or covenants contained herein is held to
cover a geographic area or to be for a length of time which is not permitted by applicable Law, or
in any way construed to be too broad or to any extent invalid, such provision shall not be
construed to be null, void and of no effect, but to the extent such provision would be valid or
enforceable under applicable Law, a court of competent jurisdiction shall construe and interpret or
reform this Section to provide for a covenant having the maximum enforceable geographic area, time
period and other provisions (not greater than those contained herein) as shall be valid and
enforceable under such applicable Law. The Identified Sellers and their Affiliates acknowledge
that Buyer and its Affiliates would be irreparably harmed by any breach of this Section 7.14 and
that there would be no adequate remedy at law or in damages to compensate Buyer and its Affiliates
for any such breach. The Identified Sellers and their Affiliates agree that Buyer and its
Affiliates shall be entitled to injunctive relief requiring specific performance by the Identified
Sellers or any of their Affiliates of this Section 7.14, and the Identified Sellers consent and
shall cause their respective Affiliates to consent to the entry thereof.

          (e) All of the covenants in this Section 7.14 shall be construed as an agreement independent
of any other provision in this Agreement, and the existence of any claim or cause of action of the
Identified Sellers or any of their respective Affiliates against Buyer or its Affiliates, whether
predicated on this Agreement or otherwise, shall not constitute a defense to the enforcement by
Buyer or its Affiliates of such covenants. The parties expressly acknowledge that the terms and
conditions of this Section 7.14 are independent of the terms and conditions of any other agreements
including, but not limited to, any employment agreements entered into in connection with this
Agreement. It is specifically agreed that the periods set forth in this Section 7.14 during which
the agreements and covenants made in this Section 7.14 shall be effective, shall be computed by
excluding from such computation any time during which the Person bound by such agreement or
covenant is found by a court of competent jurisdiction to have been in violation of any provision
of this Section 7.14. The covenants contained in this Section 7.14 shall not be affected by any
breach of any other provision hereof by any party hereto.

-54-

 

          (f) Each of the parties hereto hereby agrees that the covenants set forth in this Section 7.14
are a material and substantial part of the transactions contemplated by this Agreement and are
supported by adequate consideration.

     7.15 Shareholders Agreement. Each of the parties to the Shareholders Agreement agrees that
the Shareholders Agreement shall be terminated without any further action as of the Effective Time.

ARTICLE VIII

CONDITIONS TO CLOSING

     8.1 Conditions to Obligations of Buyer and the Sellers. The respective obligations of Buyer
and the Sellers to consummate the transactions contemplated hereby shall be subject to the
satisfaction or fulfillment, at or prior to the Closing, of each of the following conditions:

          (a) No Laws or Orders. No Governmental Entity shall have enacted, issued, promulgated,
enforced or entered any Law which is in effect and which has the effect of making any of the
transactions contemplated by this Agreement illegal or otherwise prohibiting the consummation of
any of the transactions contemplated by this Agreement.

          (b) No Injunctions. No temporary restraining order, preliminary or permanent
injunction or other Order issued by any court of competent jurisdiction or other similar legal
restraint shall be in effect that has the effect of prohibiting the consummation of any of the
transactions contemplated by this Agreement.

          (c) No Governmental Actions. There shall be no Action of any kind or character
pending or threatened by a Governmental Entity against Buyer, the Sellers or the Company, any of
their respective properties or assets, or any of their respective directors or officers (in their
capacities as such) that seeks to prohibit the consummation of any of the transactions contemplated
by this Agreement.

          (d) Regulatory Approvals/HSR Act. If applicable, all waiting periods under the HSR
Act relating to the transactions contemplated by this Agreement will have expired or terminated
early, and all material foreign antitrust approvals required to be obtained prior to the
consummation of the Share Purchase in connection with the transactions contemplated by this
Agreement, shall have been obtained.

     8.2 Additional Conditions to Obligations of Buyer. The obligations of Buyer to consummate the
transactions contemplated by this Agreement shall be subject to the satisfaction or fulfillment, at
or prior to the Closing, of each of the following additional conditions (any or all of which may be
waived, in whole or in part, exclusively by Buyer in its sole and absolute discretion):

          (a) No Company Material Adverse Effect. From the date of this Agreement, no Company
Material Adverse Effect shall have occurred.

-55-

 

          (b) Employment. Neither the Company nor Gerhard Watzinger shall have taken any action
to terminate, revoke or otherwise affirmatively repudiate Mr. Watzinger’s employment agreement with
the Company.

ARTICLE IX

INDEMNIFICATION

     9.1 Survival of Representation and Warranties.

          (a) All representations and warranties of the Company and the Sellers set forth in this
Agreement, or in any certificate or other instrument delivered pursuant to this Agreement, shall
survive the Closing and continue (regardless of any investigation made by or on behalf of, or other
knowledge of, the Parties to this Agreement) until the Escrow Release Date, provided, however, that
(i) any claim against any Party for fraud (and any representation and warranty related thereto) or
willful and knowing breach of any of clauses (a) through (v) of Section 6.1 will survive and can be
made by an Indemnified Party indefinitely, (ii) the representations and warranties of the Sellers
set forth in Article IV shall survive indefinitely, and (iii) the representations and warranties of
the Company and the Sellers set forth in Section 3.9 (Tax Matters), except for the matters
specifically set forth on Schedule 9.1(a)(iii) (which are subject to indemnification pursuant to
Section 9.2(v), which indemnification shall survive the Closing Date until the Escrow Release
Date), shall survive the Closing Date until the third (3rd) anniversary thereof (such
date, the “Tax Rep Cutoff Date”). The expiration of the representations and warranties provided
herein shall not affect the right of any Indemnified Party in respect of any claim made by such
Indemnified Party in a written notice that is delivered pursuant to and in compliance with the
provisions of this Article IX prior to the applicable expiration date specified above.

          (b) The representations and warranties of Buyer set forth in Article V of this Agreement, or
in any certificate or other instrument delivered pursuant to this Agreement, shall survive
indefinitely.

     9.2 Indemnification by Sellers. Subject to the limits set forth in this Article IX, from and after
the Closing, the Sellers agree to indemnify, defend and hold harmless Buyer, its Affiliates
(including, after the Closing Date, the Company and its Subsidiaries), and their Representatives
(the “Indemnified Parties,” and each, an “Indemnified Party”) from and in respect of any and all
losses, damages, costs and expenses (including, demands, suits, claims, actions, assessments,
liabilities, judgments, reasonable expenses of investigation and the reasonable fees and expenses
of counsel and other professionals incurred in connection with investigating, defending against or
settling any of the foregoing) (collectively, “Losses”; and individually, a “Loss”), that such
Indemnified Party may suffer, sustain or become subject to, directly or indirectly, as a result of,
in connection with, or relating to, (i) any breach of any representation or warranty of the Company
or Seller contained in Article III and Article IV of this Agreement or any certificate delivered
pursuant hereto (determined, in each case, without giving effect to any qualification as to
materiality, but not for the avoidance of doubt “Company Material Adverse Effect,” set forth
therein); (ii) any breach by the Company or any Seller of any pre-Closing covenant, undertaking or
other agreement of the Company or any Seller contained in this Agreement; (iii) any Excess Third
Party Expenses;

-56-

 

(iv) breach by any Seller of any post-Closing covenant, undertaking or other
agreement of any Seller contained in this Agreement; and (v) the matters specifically set forth on
Schedule 9.1(a)(iii). Any amount paid to the Indemnified Parties pursuant to this Section 9.2 will
be treated as an adjustment to the Purchase Price. The Indemnifying Parties shall not have any
right of contribution, indemnification or right of advancement from the Company or Buyer with
respect to any Loss claimed by an Indemnified Party. Nothing in this Agreement shall limit the
right of Buyer or any Indemnified Party to pursue remedies under any Ancillary Agreement against
the parties thereto.

     9.3 Indemnification Limitations.

          (a) Notwithstanding anything to the contrary contained in this Agreement, (i) no
indemnification shall be available in respect of Section 9.2(i) unless (A) other than with respect
to the Specified Representations and the matters set forth on Schedule 9.1(a)(iii), the aggregate
amount (without duplication) of Losses of the Indemnified Parties with respect thereto exceeds
$1,000,000 (the “Basket Amount”), in which case the Indemnified Parties shall be entitled to be
indemnified only for those Losses in excess of the Basket Amount, and (B) other than with respect
to the matters set forth on Schedule 9.1(a)(iii), the Losses relating to any individual claim, or
series of related claims that are based primarily on a similar set of operative facts, is greater
than $50,000; (ii) the aggregate maximum liability for indemnification pursuant to Section 9.2
including the matters specifically set forth on Schedule 9.1(a)(iii) shall be the Escrow Amount and
recourse therefor shall be solely against the Escrow Fund, provided that, the Buyer may recover for
any breaches of the representations and warranties of the Company and/or the Sellers set forth in
(x) Section 3.9 (Tax Matters) and (y) Article IV ((x) and (y), the “Specified Representations”) in
accordance with Section 9.3(a)(iii), (iii) upon and after the Escrow Release Date any
indemnification pursuant to Section 9.2(i) for (A) any breaches of the representations and
warranties of the Sellers set forth in Article IV or pursuant to Section 9.2(iv) shall be solely
against the breaching Seller, severally and
not jointly, and no other Seller shall have any liability whatsoever with respect thereto and
any such indemnification from any Seller shall be limited in the aggregate to that portion of the
Purchase Price actually received by such Seller and (B) any breaches of the representations and
warranties set forth in Section 3.9 (Tax Matters), except for the matters specifically set forth on
Schedule 9.1(a)(iii), shall be against the Sellers, severally and not jointly, and any such
indemnification from any Seller pursuant to this Section 9.3(a)(iii)(B) shall be limited in the
aggregate to an amount equal to such Seller’s Pro Rata Portion of the Remaining Escrow Amount, (iv)
the amount of any and all Losses under this Article IX shall be determined net of (a) any Tax
benefits actually recognized in the year of payment of such Loss or any of the two years thereafter
by any party seeking indemnification hereunder by a reduction in cash Taxes payable in such year by
such party arising from the deductibility of any such Losses (and if any such Tax benefit is
realized after the Indemnified Party collected indemnification amounts hereunder, the amount of
such Tax benefits shall be refunded to the Escrow Fund or, after the Escrow Fund has terminated,
the Sellers’ Representative on behalf of the Sellers), and (b) any amounts actually recovered under
or pursuant to any insurance policy, title insurance policy, indemnity, reimbursement arrangement
or contract pursuant to which or under which such Indemnified Party or such Indemnified Party’s
Affiliates is a party or has rights (collectively, “Alternative Arrangements”), in each case net of
collection costs, and (v) in no event shall any Indemnified Party be entitled to recover or make a
claim for any amounts in respect of, and

-57-

 

in no event shall “Losses” be deemed to include, (a)
punitive, special or exemplary damages (other than any such Losses incurred by an Indemnified Party
as a result of any final and non-appealable judgment granted to a third party) and, in particular,
no “multiple of profits” or “multiple of cash flow” or similar valuation methodology shall be used
in calculating the amount of any Losses, or (b) any loss, liability, damage or expense to the
extent specifically accrued or reserved for as a liability on the Company Balance Sheet in
accordance with IFRS applied on a basis consistent with past practices.

          (b) Nothing in this Article IX or otherwise set forth in this Agreement shall limit or
preclude any claim against any Party for fraud or for any willful and knowing breach of any of
clauses (a) through (v) of Section 6.1 of this Agreement.

          (c) Notwithstanding anything to the contrary herein, the parties hereto agree and acknowledge
that any Indemnified Party may bring a claim for indemnification for any Loss under this Article IX
notwithstanding the fact that such Indemnified Party had knowledge of the breach, event or
circumstance giving rise to such Loss prior to Closing or waived any condition to the Closing
related thereto.

          (d) In the event that an Indemnified Party suffers, sustains or becomes subject to any Loss
which is subject to indemnification under Section 9.2(v), as a result of, in connection with or
relating to an event or series of events, which, in the reasonable opinion of the Sellers’
Representative, would entitle the Company to make an indemnification claim under the 2005 Share
Purchase Agreement, then the Sellers’ Representative shall be entitled to instruct the Company to
take (at the expense of the Sellers), all such actions as the Seller may reasonably require to make
and/or enforce such claim against the relevant parties to the 2005 Share Purchase Agreement. In
the event that the Company recovers any amount pursuant to such claim, then such amount (net of any
unpaid expenses of the Company and any Tax consequences to the Company or any of its
Affiliates as a result of such recovery or as a result of such recovery being for the account of or
paid to the Sellers or returned to the Escrow Account) shall be for the account of the Sellers,
provided that, in the event such recovery occurs prior to the Escrow Release Date, than the amount
of such recovery shall be returned to the Escrow Account. The Parties agree to cooperate to ensure
that any recovery and subsequent payments made pursuant to this Section 9.3(d) shall be made in the
most tax efficient manner possible.

     9.4 Escrow; Claim Procedures

          (a) From and after the Closing, the Sellers agree that, subject to the other provisions of
this Article IX and the terms and conditions of the Escrow Agreement, the Escrow Amount shall be
available to indemnify, defend and hold harmless the Indemnified Parties from and against any and
all Losses in respect of which such Indemnified Parties may be indemnified, defended or held
harmless under this Article IX. Sellers’ interests in the Escrow Amount shall be non-transferable.

          (b) In the event that any Indemnified Party has a right to indemnification on or prior to the
Escrow Release Date pursuant to Section 9.2, Buyer may send a written notice to the

-58-

 

Sellers’
Representative on or prior to the Escrow Release Date stating that an Indemnified Party has a right
to receive payment and specifying in reasonable detail the basis for its claim, as well as the
Losses relating thereto (which, if not determinable at such time, may be a reasonable good faith
estimate thereof) (a “Payment Notice”). The failure to so notify the Sellers’ Representative shall
not relieve the Sellers of any liability, except to the extent the Indemnifying Parties are
economically prejudiced or otherwise prejudiced, in any material respect, thereby or the extent
such Payment Notice is not delivered prior to the Escrow Release Date. Unless the Sellers’
Representative delivers a written notice to Buyer within twenty (20) Business Days after receipt of
the Payment Notice specifying in reasonable detail any objections to the Payment Notice, the
Sellers’ Representative and Buyer shall deliver to the Escrow Agent a written notice executed by
both Parties instructing the Escrow Agent to deliver to Buyer the amount designated in such Payment
Notice subject to the terms of this Agreement and the Escrow Agreement. If the Sellers’
Representative notifies Buyer of such an objection to the Payment Notice, (i) the Sellers’
Representative and Buyer shall deliver to the Escrow Agent a written notice executed by both
Parties instructing the Escrow Agent to deliver to Buyer, subject to the terms and conditions of
this Agreement and the terms and conditions of the Escrow Agreement, the amount designated in such
Payment Notice that is not subject to dispute, if any, and (ii) the parties shall in good faith
attempt for ten (10) days to resolve their differences with respect to the amount designated in
such Payment Notice that is subject to dispute. If a dispute remains as to any amount designated
in such Payment Notice following the expiration of such ten (10) day period, each party shall be
entitled to seek any available remedy against the other party in accordance with Section 9.2 and
Section 9.3.

          (c) Subject to and in accordance with the terms and conditions of the Escrow Agreement, upon
the Escrow Release Date, any remaining portion of the Escrow Fund (such amount, the “Remaining
Escrow Amount”) shall promptly be delivered to the Sellers; provided,
however, that the Escrow Fund shall not terminate with respect to, and to the extent that, any
such amounts (the aggregate of such amounts, the “Holdback Amount”) are reasonably necessary to
satisfy any unsatisfied claims specified in any Payment Notice delivered to the Sellers’
Representative on or prior to the Escrow Release Date. As soon as any such claims have been
resolved (any such resolved claim, a “Resolved Claim”), the Sellers’ Representative and Buyer shall
deliver to the Escrow Agent a written notice executed by both Parties instructing the Escrow Agent
to deliver to each Seller such Seller’s applicable Escrow Distribution (after deducting the amount
required to be distributed pursuant to the resolution of such claim to the applicable Indemnified
Parties) in accordance with the terms and conditions of this Agreement and the Escrow Agreement.
In addition, should the Holdback Amount, or any portion thereof, at any time cease to constitute a
Holdback Amount pursuant to the definition thereof, the Sellers’ Representative and Buyer shall
deliver to the Escrow Agent a written notice executed by both Parties instructing the Escrow Agent
to pay each Seller such Seller’s applicable Escrow Distribution in accordance with the terms of
this Agreement and the Escrow Agreement.

          (d) In the event that any claim, action or proceeding is made, brought or initiated by any
third party against an Indemnified Party giving rise to indemnity pursuant to this Article IX,
Buyer shall, as promptly as practicable, so notify the Sellers’ Representative in writing,
specifying in reasonable detail the basis of the Indemnified Party’s belief that such claim, action
or proceeding

-59-

 

gives rise to indemnity pursuant to Article IX (the “Third Party Claim Notice”). The
failure to so notify the Sellers’ Representative shall not relieve the Sellers of any liability,
except to the extent the Indemnifying Parties are economically prejudiced or otherwise prejudiced,
in any material respect, thereby or (other than with respect to any such Third Party Claim
contemplated by Section 9.3(a)(iii)) to the extent such Third Party Claim Notice is not delivered
on or prior to the Escrow Release Date. The Sellers’ Representative shall have the right in its
sole discretion, but not the obligation, to assume the defense of any such claim, action or
proceeding and to defend, in good faith, any such claim, action or proceeding, and Buyer shall have
the right (at its expense), but not the obligation, to participate in (but not control), the
defense of any such third-party claim, action or proceeding. If the Sellers’ Representative fails
to assume the defense of such third party claim in accordance with this Section 9.4(d) within
thirty (30) days after receipt of notice of such claim pursuant hereto, Buyer shall (upon
delivering notice to such effect to the Sellers’ Representative) have the right to undertake the
defense of such third party claim, and the Sellers’ Representative shall be liable for any
resulting settlement of such third party claim and for any final judgment with respect thereto
(subject to any right of appeal), if any, but only to the full extent otherwise provided in this
Agreement. In the event the Sellers’ Representative assumes the defense of the claim pursuant to
this Section 9.4(d), the Sellers’ Representative shall keep the Indemnified Party reasonably
informed of the progress of any such defense or settlement, and in the event Buyer assumes the
defense of the claim pursuant to this Section 9.4(d), Buyer shall keep the Sellers’ Representative
reasonably informed of the progress of any such defense or settlement. Buyer shall not settle such
third-party claim without the prior written consent of the Sellers’ Representative, which consent
shall not be unreasonably withheld or delayed; provided, however, that if the Sellers’
Representative affirmatively abandons the defense of any such third party claim, the Sellers’
Representative’s consent shall not be required for any such settlement. The Sellers’
Representative may not settle or compromise such third-party claim without the prior written
consent of Buyer,
which consent shall not be unreasonably withheld or delayed; provided, that notwithstanding
the foregoing, Buyer shall be entitled not to consent, in its sole discretion, to any proposed
settlement or compromise that (i) does not include a provision whereby the plaintiff or claimant in
the matter releases Buyer and its Affiliates from all Liability with respect thereto (which shall
be in form and substance satisfactory to Buyer, or (ii) would obligate Buyer or any of its
Affiliates to pay or be liable for an amount related thereto in excess of the amount then available
for indemnification hereunder. Buyer shall make available to the Sellers’ Representative all
records and other materials reasonably required for use in contesting any third-party claim,
subject to any privileged or confidential information. Buyer shall use commercially reasonable
efforts to cooperate with the Sellers’ Representative in the defense of all such claims. Any
expenditures by the Sellers’ Representative in defense of a third party claim subject to this
Section 9.4(d) shall constitute Sellers’ Representative Expenses.

     9.5 Exclusive Remedy. Buyer acknowledges and agrees that, from and after the Closing, and
other than actions for specific performance or similar injunctive relief or actions against a Party
committing for fraud or any willful and knowing breach of any of clauses (a) through (v) of Section
6.1 of this Agreement, its and the other Indemnified Parties’ sole and exclusive remedy with
respect to any and all claims relating to the subject matter of this Agreement and the transactions
contemplated hereby shall be pursuant to the indemnification provisions set forth in this Article
IX

-60-

 

and, other than with respect to indemnification pursuant to Section 9.2(i) with respect to the
Specified Representations and indemnification pursuant to Section 9.2(iv), shall be limited to the
Escrow Amount and recourse therefor shall be solely against the Escrow Fund.

     9.6 Sellers’ Representative.

          (a) The Sellers, by executing this Agreement, irrevocably appoint Summit Partners III,
S.a.r.l. as the “Sellers’ Representative,” their agent and attorney-in-fact to act on behalf of
each of the Sellers, in connection with and to facilitate the consummation of the transactions
contemplated hereby and the Escrow Agreement, which shall include the power and authority:

               (i) for the purposes of Article IX, to give and receive notices and communications, to
authorize delivery to any Indemnified Party of cash from the Escrow Amount in satisfaction of
claims by an Indemnified Party, to object to such deliveries, to agree to, negotiate, enter into
settlements and compromises of, and demand arbitration and comply with orders of courts and awards
of arbitrators with respect to such claims, and to take all actions necessary or appropriate in the
judgment of the Sellers’ Representative for the accomplishment of the foregoing. The Sellers’
Representative shall inform the Sellers within three (3) Business Days of any action taken by it
hereunder;

               (ii) to execute and deliver the Escrow Agreement (with such modifications or changes therein
as to which the Sellers’ Representative, in its sole discretion, shall have
consented) and to agree to such amendments or modifications thereto as the Sellers’
Representative, in its sole discretion, determines to be desirable;

               (iii) to execute and deliver such waivers and consents in connection with this Agreement and
the Escrow Agreement and the consummation of the transactions contemplated hereby and thereby as
the Sellers’ Representative, in its sole discretion, may deem necessary or desirable;

               (iv) to enforce and protect the rights and interests of the Sellers and to enforce and protect
the rights and interests of all Sellers arising out of or under or in any manner relating to this
Agreement and the Escrow Agreement, and any other document contemplated hereby, and to take any and
all actions which the Sellers’ Representative believes are necessary or appropriate under either of
the Escrow Agreement and/or this Agreement for and on behalf of the Sellers;

               (v) to refrain from enforcing any right of the Sellers or any of them and/or the Sellers’
Representative arising out of or under or in any manner relating to this Agreement, the Escrow
Agreement or any document contemplated hereby; provided, however, that no such failure to act on
the part of the Sellers’ Representative, except as otherwise provided in this Agreement or in the
Escrow Agreement, shall be deemed a waiver of any such right or interest by the Sellers’
Representative or by the Sellers unless such waiver is in writing signed by the waiving party or by
the Sellers’ Representative;

-61-

 

               (vi) to make, execute, acknowledge and deliver all such other agreements, guarantees, orders,
receipts, endorsements, notices, requests, instructions, certificates, stock powers, letters and
other writings, and, in general, to do any and all things and to take any and all action that the
Sellers’ Representative, in its sole and absolute discretion, may consider necessary or proper or
convenient in connection with or to carry out the transactions contemplated by this Agreement, the
Escrow Agreement and all other documents contemplated hereby; and

               (vii) to direct payment from the Closing Cash Payment to pay any fees or expenses incurred or
agreed to be incurred by a Seller in connection with the negotiation and effectuation of this
Agreement, such amounts to be borne by each Seller in proportion to its pro rata share of the
Aggregate Participation Consideration, provided, that, each Seller must make the Seller’s
Representative aware of such fees or expenses by the Closing Date, and, provided, further, that any
fees and expenses that the Seller’s Representative is not made aware of by the Closing Date shall
be for the account of the Seller that incurred them.

          (b) The Sellers’ Representative may resign upon written notice to Buyer and the holders of a
majority interest of the Escrow Amount shall appoint a successor. The successor shall be entitled
to all the rights, powers, immunities and privileges as was his, her or its predecessor, without
the need of any further act or writing. No bond shall be required of the Sellers’ Representative,
and the Sellers’ Representative shall not receive compensation for his, her or its services.
Notices or communications to or from the Sellers’ Representative shall constitute notice to or from
each of the Sellers.

          (c) The Sellers’ Representative shall not be liable for any act done or omitted hereunder as
Sellers’ Representative while acting in good faith and in the exercise of reasonable judgment. The
Sellers’ Representative shall only have the duties expressly stated in this Agreement and shall
have no other duty, express or implied. The Sellers’ Representative may engage attorneys,
accountants and other professionals and experts. The Sellers’ Representative may in good faith
rely conclusively upon information, reports, statements and opinions prepared or presented by such
professionals, and any action taken by the Sellers’ Representative based on such reliance shall be
deemed conclusively to have been taken in good faith and in the exercise of reasonable judgment.
The Sellers’ Representative will serve without compensation but will, except as otherwise provided
herein, be reimbursed by each Seller, severally and not jointly in accordance with such Seller’s
Pro Rata Portion, for any reasonable out-of-pocket expenses incurred or anticipated to be incurred
in good faith on the part of the Sellers’ Representative and arising out of or in connection with
the acceptance or administration of the Sellers’ Representative’s duties hereunder, including the
reasonable fees and expenses of any legal counsel retained by the Sellers’ Representative
(“Sellers’ Representative Expenses”). Following the resolution of all pending claims related to
the Sellers’ Representative’s duties hereunder, the Sellers’ Representative shall have the right to
recover Sellers’ Representative Expenses from the any remaining funds in the Escrow Fund to be
distributed to the Sellers prior to any distribution to the Sellers, and prior to any such
distribution, shall deliver to the Escrow Agent a certificate setting forth the Sellers’
Representative Expenses actually incurred. The Sellers shall indemnify, severally but not jointly,
up to an amount proportional to such Seller’s Pro Rata Portion, the Sellers’ Representative and
hold the Sellers’ Representative harmless against any

-62-

 

loss, liability or expense incurred on the
part of the Sellers’ Representative (so long as the Sellers’ Representative was acting in good
faith in connection therewith) and arising out of or in connection with the acceptance or
administration of the Sellers’ Representative’s duties hereunder, including the reasonable fees and
expenses of any legal counsel retained by the Sellers’ Representative; provided, however, that the
Sellers’ Representative shall first seek recovery for any such loss, liability or expense from the
Escrow Fund, and only thereafter in accordance with the terms of this Agreement.

          (d) A decision, act, consent or instruction of the Sellers’ Representative with respect to the
matters for which the Sellers’ Representative is authorized pursuant to this Section 9.6 shall
constitute a decision of all of the Sellers and shall be final, legally binding and conclusive.
Buyer shall have the right to rely upon all actions taken or omitted to be taken by the Sellers’
Representative pursuant to this Agreement and the Escrow Agreement. With respect to matters
regarding the Escrow Amount, the Indemnified Parties may rely upon any such decision, act, consent
or instruction of the Sellers’ Representative as being the decision, act, consent or instruction of
each Seller. The Indemnified Parties are hereby relieved from any liability to any Person for any
acts done by them in accordance with such decision, act, consent or instruction of the Sellers’
Representative.

          (e) Buyer, on behalf of all Indemnified Parties, hereby agrees that any notice, right, or
obligation required to be delivered to, performed by, or asserted by the Sellers regarding the
Escrow Amount shall be delivered to, performed by or asserted by the Sellers’ Representative.

          (f) The grant of authority provided for herein to the Sellers’ Representatives (i) is coupled
with an interest and shall be irrevocable and survive the death, incompetency, bankruptcy or
liquidation of any Seller and (ii) shall survive the consummation of the Share Purchase, and any
action taken by the Sellers’ Representative pursuant to the authority granted in this Agreement or
under the Escrow Agreement shall be effective and absolutely binding on each Seller notwithstanding
any contrary action of or direction from such holder.

          (g) The Sellers’ Representative may at any time resign by giving written notice of its
resignation to Buyer and the Sellers specifying the date on which its resignation shall become
effective; provided, that such date shall be at least thirty (30) days after the receipt of such
notice, unless Buyer and the Sellers agree to accept shorter notice. Prior to resignation, the
Sellers’ Representative shall appoint a replacement Sellers’ Representative. Such appointment
shall be evidenced by a written instrument from such replacement Sellers’ Representative accepting
such appointment, a copy of which shall be delivered to Buyer and notice of which such appointment
shall be given to the Sellers. Notwithstanding the date of effectiveness specified in such written
notice of resignation, the resignation shall become effective only upon the acceptance of
appointment by the successor Sellers’ Representative.

ARTICLE X  

TERMINATION

     10.1 Termination. This Agreement may be terminated prior to the Closing upon written notice
to the other referenced Parties as follows:

-63-

 

          (a) by the mutual written consent of Buyer, the Sellers and the Company;

          (b) by either Buyer, on the one hand, or the Sellers (acting as a group), on the other hand,
if the Closing shall not have occurred by the date that is sixty (60) days from the date which is
the earlier of (i) the filing of the joint notification and application for the clearance of the
Share Purchase with the German competition authorities and (ii) October 15, 2007; provided,
however, that the right to terminate this Agreement under this subsection shall not be available to
any party whose failure to fulfill any obligation under this Agreement shall have been the primary
cause of, or resulted in, the failure of the Closing to occur prior to such date;

          (c) by either Buyer or the Sellers (acting as a group) if a Governmental Entity shall have
issued an Order or taken any other action (including the failure to have taken an action), in any
case having the effect of permanently restraining, enjoining or otherwise prohibiting the Share
Purchase, which order, decree, ruling or other action is final and nonappealable;

          (d) by Buyer, if from the date of this Agreement there shall have occurred any Company
Material Adverse Effect; and

          (e) by Buyer, if there has been a breach of the representations and warranties contained in
Section 4.1 or Section 4.4 that would prevent any Seller from being able to consummate the Share
Purchase.

     10.2 Effect of Termination. In the event of termination of this Agreement as permitted by
Section 10.1, this Agreement shall become void and of no further force and effect, except for the
following provisions, which shall remain in full force and effect: Sections 7.2, 7.13, this
Section 10.2, Article XI and Article XII. Nothing in this Section 10.2 shall be deemed to release
any Party from any liability for any breach by such party of the terms and provisions of this
Agreement prior to any such termination or to impair the right of any party to compel specific
performance by any other party of its obligations under this Agreement.

ARTICLE XI

GUARANTEES

     11.1 Liability for Payment of Purchase Price. Parent, as primary obligor, hereby absolutely,
unconditionally and irrevocably guarantees to each of the Sellers the performance of any and all
obligations of Buyer pursuant to this Agreement (the “Buyer Obligations”), including, but not
limited to, the delivery of the Closing Cash Payment (the “Parent Guarantee”).

     11.2 Nature of Guarantee. The Sellers shall not be obligated to file any claim relating to
Buyer Obligations in the event that Buyer becomes subject to a bankruptcy, reorganization or
similar proceeding, and the failure of the Sellers to so file shall not affect Parent’s obligations
hereunder. In the event that any payment to the Sellers in respect of Buyer Obligations is
rescinded or must otherwise be returned to the payor for any reason whatsoever, Parent shall remain
liable hereunder with respect to Buyer Obligations as if such payment had not been made. This is
an unconditional guarantee of payment and not of collectibility. Upon the failure of Buyer
to
fulfill Buyer

-64-

 

Obligations in accordance with this Agreement, Parent shall, on demand and without
presentment, protest, any notice whatsoever, all such notices being hereby waived, perform or pay
such Buyer Obligations, and it shall not be necessary for the Sellers, in order to enforce such
payment or performance by Parent, first to institute suit or pursue or exhaust any rights or
remedies against Buyer, or to resort to any other means of obtaining payment or performance of
Buyer Obligations. Time shall be of the essence in this Parent Guarantee with respect to all of
Parent’s obligations hereunder.

     11.3 Parent Representations and Warranties. Parent represents and warrants as of the date
hereof and as of the Closing Date that it has all requisite corporate power and authority to enter
into this Agreement and, subject to satisfaction of the conditions set forth herein, to fulfill its
obligations hereunder. The execution and delivery of this Agreement and the consummation of the
transactions contemplated hereby have been duly authorized by all necessary corporate action on the
part of Parent, and no further action is required on the part of Parent or its stockholders to
authorize
the Agreement and the transactions contemplated hereby. This Agreement has been duly executed
and delivered by Parent and this Agreement constitutes legal, valid and binding obligations of
Parent enforceable against Parent in accordance with its terms, subject to the effect of applicable
bankruptcy, insolvency, reorganization or other similar Laws affecting the rights of creditors and
the effect or availability of rules of Law governing specific performance, injunctive relief or
other equitable remedies.

     11.4 Unconditional Guaranty. Mr. Paul Gootaers, as primary obligor, hereby absolutely,
unconditionally and irrevocably guarantees to Buyer the performance of any and all obligations of
CBB pursuant to this Agreement (the “CBB Obligations”), including but not limited to the
indemnification and other obligations contained in Article IX hereto (the “Grootaers Guarantee”).

     11.5 Nature of Guarantee. Buyer shall not be obligated to file any claim relating to CBB
Obligations in the event that CBB becomes subject to a bankruptcy, reorganization or similar
proceeding, and the failure of Buyer to so file shall not affect Mr. Grootaers’s obligations
hereunder. In the event that any payment to Buyer in respect of the CBB Obligations is rescinded
or must otherwise be returned to the payor for any reason whatsoever, Mr. Grootaers shall remain
liable hereunder with respect to the CBB Obligations as if such payment had not been made. This is
an unconditional guarantee of payment and not of collectibility. Upon the failure of CBB to
fulfill the CBB Obligations in accordance with this Agreement, Mr. Grootaers shall, on demand and
without presentment, protest, any notice whatsoever, all such notices being hereby waived, perform
or pay such CBB Obligations, and it shall not be necessary for Buyer, in order to enforce such
payment or performance by Mr. Grootaers, first to institute suit or pursue or exhaust any rights or
remedies against CBB, or to resort to any other means of obtaining payment or performance of the
CBB Obligations. Time shall be of the essence for this Grootaers Guarantee with respect to all of
Mr. Grootaers’s obligations hereunder.

     11.6 Mr. Paul Grootaers’s Representations and Warranties. Mr. Paul Grootaers represents and
warrants as of the date hereof and as of the Closing Date that he has full power and authority,
including any spousal consent required by applicable Law, and legal capacity to execute

-65-

 

this
Agreement and, subject to the conditions hereunder, to perform his obligations hereunder. This
Agreement has been duly executed and delivered by Mr. Grootaers and this Agreement constitutes
legal, valid and binding obligations of Mr. Grootaers enforceable against Mr. Grootaers in
accordance with its terms, subject to the effect of applicable bankruptcy, insolvency,
reorganization or other similar Laws affecting the rights of creditors and the effect or
availability of rules of Law governing specific performance, injunctive relief or other equitable
remedies.

ARTICLE XII

GENERAL

     12.1 Amendment. This Agreement may only be amended by the Parties hereto by execution of an
instrument in writing validly executed by (i) Buyer, (ii) Sellers holding a majority of the total
Company Ordinary Shares outstanding as of the date hereof, provided that, if any such amendment
would adversely and
uniquely affect any Seller or holder of Company Options, the consent of such Seller or holder of
Company Options shall also be required, and (iii) the Company. Any such amendment of this Agreement
effectuated in accordance with this Section 12.1 shall be binding on each Seller and all Sellers
shall be deemed to have agreed to it.

     12.2 Waiver. Neither any failure nor any delay by any party in exercising any right, power or
privilege under this Agreement or any of the Ancillary Agreements will operate as a waiver of such
right, power or privilege, and no single or partial exercise of any such right, power or privilege
will preclude any other or further exercise of such right, power or privilege or the exercise of
any other right, power or privilege. To the maximum extent permitted by applicable Law, (a) no
claim or right arising out of this Agreement or any Ancillary Agreements can be discharged by one
party, in whole or in part, by a waiver or renunciation of the claim or right unless in writing
signed by the other party; (b) no waiver that may be given by a party will be applicable except in
the specific instance for which it is given; and (c) no notice to or demand on one party will be
deemed to be a waiver of any obligation of that party or of the right of the party giving such
notice or demand to take further action without notice or demand as provided in this Agreement or
any Ancillary Agreements. Any extension or waiver by any party of any provision hereto shall be
valid only if set forth in an instrument in writing signed on behalf of such party.

     12.3 Notices. All notices, requests, demands, and other communications under this Agreement
shall be in writing and shall be deemed to have been duly given on the date of service if served
personally or by commercial messenger or courier service on the Party to whom notice is to be
given, or on the third day after mailing if mailed to the Party to whom notice is to be given, by
first class mail registered or certified, postage prepaid, and properly addressed as follows:

     If to Parent or Buyer: McAfee, Inc.

3965 Freedom Circle

Santa Clara, CA 95054

Attention: Mark Cochran, Executive Vice President and General Counsel

Facsimile: (408) 346-3314

-66-

 

with a copy (which shall not constitute notice) to:

Wilson Sonsini Goodrich & Rosati

Professional Corporation

650 Page Mill Road

Palo Alto, CA 94304

Attention: Robert G. Day

 Lawrence M. Chu

Facsimile: (650) 493-6811

and

NautaDutilh N.V.

P.O. Box 1110

3000 BC Rotterdam, The Netherlands

Facsimile: +31 10 22 40 005

Attention: Gijs Rooijens

 Martin Grablowski

     If to the Sellers’ Representative:

Summit Partners Limited

Berkeley Square House

8th Floor

Berkeley Square

London W1J 6DB United Kingdom

Attention: Scott Collins

 Sotiris T.F.Lyritzis

with a copy (which shall not constitute notice) to:

Kirkland & Ellis LLP

30 St Mary Axe

London, EC3A 8AF United Kingdom

Facsimile: +44 20 7469 2001

Attention: James L. Learner

     If to the Sellers (as applicable):

Summit Partners III S.a.r.l.

c/o Summit Partners Limited

Berkeley Square House

8th Floor

-67-

 

Berkeley Square

London W1J 6DB United Kingdom

Attention: Scott Collins

 Sotiris T.F.Lyritzis

and

Mr. Gerhard Watzinger

2821 Tarflower Way

Naples, FL, 34105, United States of America

Facsimile: +1 239 430 1916

and

Control Break Beheer B.V.

Portengen 27

3628 EB Kockengen, The Netherlands

Facsimile: +31 (0) 346 242 410

in each case, with a copy (which shall not constitute notice) to:

Kirkland & Ellis LLP

30 St Mary Axe

London, EC3A 8AF United Kingdom

Facsimile: +44 20 7469 2001

Attention: James L. Learner

     If to the Company:

Safeboot Holding B.V.

Edisonbaan 15

3439 MN Nieuwrgien, The Netherlands

Facsimile: +31 (0) 30 634 88 99

Attention: Gerhard Watzinger

  Piet Weijers

with a copy (which shall not constitute notice) to:

AKD Prinson vsn Wijmen N.V.

Admiraliteitskade 50

3063 ED Rotterdam, The Netherlands

Facsimile: +31 (0) 88 253 55 73

Attention: Natalie van Woerkum

-68-

 

     If to the Stichting:

Stichting Administratiekantoor SafeBoot

Prins Bernhardplein 200

1097 JB Amsterdam, The Netherlands

Facsimile: +31 (0) 20 521 48 88

Attention: Jaap Veerman

     If to Mr. Paul Grootaers:

Mr. Paul Grootaers

c/o Control Break Beheer B.V.

Portengen 27

3628 EB Kockengen, The Netherlands

Facsimile: +31 (0) 346 242 410

     12.4 No Third Party Beneficiaries. This Agreement, the Exhibits hereto, the Disclosure
Schedule, the Ancillary Agreements, and the documents and instruments and other agreements among
the Parties hereto referenced herein are not intended to, and shall not, confer upon any other
Person any rights or remedies hereunder, except as set forth in Article IX hereto with respect to
any Indemnified Parties, which shall be deemed as third-party beneficiaries of the Sellers’
indemnification obligations hereunder.

     12.5 Entire Agreement. This Agreement, the Exhibits hereto, the Disclosure Schedule, the
Ancillary Agreements, and the documents and instruments and other agreements among the Parties
hereto referenced herein constitute the entire agreement among the Parties with respect to the
subject matter hereof and supersede all prior agreements and understandings both written and oral,
among the Parties with respect to the subject matter hereof.

     12.6 Governing Law. This Agreement shall be governed by and construed in accordance with the
laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable
principles of conflicts of laws thereof.

     12.7 Consent to Jurisdiction. Each of the Parties hereto unconditionally and irrevocably (a)
consents to submit itself to the jurisdiction of any federal or state court located in the State of
Delaware (“Delaware Court”) in the event of any dispute arising out of or relating to this
Agreement or the Share Purchase and the transactions contemplated hereby, or the breach,
termination or validity thereof, (b) agrees that it will not attempt to deny or defeat such
jurisdiction by motion or other request for leave from any such Delaware Court and irrevocably
waives any objections which it may have now or in the future to the jurisdiction of any Delaware
Court including without limitation objections by reason of lack of personal jurisdiction, improper
venue, or inconvenient forum and (c) agrees that it will not bring any action relating to this
Agreement or the Share Purchase and the transactions contemplated hereby in any court other than a
Delaware Court, except for an action to enforce an order or judgment of a Delaware Court.

-69-

 

     12.8 Assignment. This Agreement, the Exhibits hereto, the Disclosure Schedule, the Ancillary Agreements, and
the documents and instruments and other agreements among the Parties hereto referenced herein shall
not be assigned by operation of law or otherwise, except that Buyer may assign its rights and
delegate its obligations hereunder to its affiliates, provided, that Buyer remains ultimately
liable for all of Buyer’s obligations hereunder.

     12.9 Counterparts. This Agreement may be signed by the Parties in counterparts and the
signature pages combined shall create a document binding on all Parties.

     12.10 Severability. If any provision of the Agreement is held to be invalid or unenforceable
at Law, that provision will be reformed as a valid provision to reflect as closely as possible the
original provision giving maximum effect to the intent of the Parties, or if that cannot be done,
will be severed from the Agreement without affecting the validity or enforceability of the
remaining provisions.

     12.11 Specific Performance. The Parties agree that irreparable damage would occur in the
event any provision of this Agreement was not performed in accordance with the terms thereof and
that, prior to the termination of this Agreement pursuant to its terms, the Parties shall be
entitled to seek specific performance of the terms hereof, in addition to any other remedy at law
or equity.

     12.12 Waiver of Jury Trial. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO
TRIAL BY JURY AND ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT, OR
OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF ANY PARTY HERETO IN
NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT HEREOF.

     12.13 No Additional Representations. Buyer acknowledges and agrees that none of the Sellers
or the Company nor any of their Affiliates or representatives, nor any other Person acting on
behalf of the Sellers or the Company or any of their respective Affiliates or representatives has
made any representation or warranty, express or implied, as to the accuracy or completeness of any
information regarding the Sellers, the Company or its Subsidiaries or their respective businesses
or assets, except as expressly set forth in this Agreement or as and to the extent required by this
Agreement to be set forth in the Disclosure Schedule or any certificate or instrument delivered
pursuant hereto.

[Remainder of Page Intentionally Left Blank]

-70-

 

     IN WITNESS WHEREOF, this Agreement has been duly executed by the Parties hereto as of the date
first above written.

	 	 	 	 	 
	 	 	MCAFEE EUROPEAN HOLDINGS LIMITED
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 	 	MCAFEE, INC.
	 	 	(solely for purposes of Article XI (and the
	 	 	provisions of Article XII relating to the
	 	 	foregoing))
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 	 	SAFEBOOT HOLDING B.V.
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	STICHTING ADMINISTRATIEKANTOOR SAFEBOOT
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 

 

 

	 	 	 	 	 
	 	 	SUMMIT PARTNERS III S.Á.R.L (in its capacity as
	 	 	a Seller and as the Sellers’ Representative)
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 	 	CONTROL BREAK BEHEER B.V.
	 

	 	By:	 	 
	 

	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 	 	PAUL GROOTAERS (solely for the purposes of
	 	 	Section 7.14, Section 7.15, Article XI and the
	 	 	provisions of Article XII relating thereto)
	 
	 	 	 	 
	 	 	 
	 	 	GERHARD WATZINGERexv10w33

 

Exhibit 10.33

McAFEE, INC.

Amendment of Stock Options

     By electing to amend your discount options, the outstanding Stock Option Agreements (the
“Agreements”) related to grants number 32125 and 31443 under the McAfee, Inc. (the “Company”) 1997
Stock Incentive Plan and the Networks Associates, Inc. 2000 Nonstatutory Stock Option Plan (the
“Plans”) by and between the Company and William Kerrigan (“Optionee”) are hereby amended as
follows:

     Unless otherwise defined herein, initially capitalized terms shall have the same meanings as
defined in the Plan.

     1. Effective Date. This Amendment of Stock Options and Election to Amend Stock
Options (“Amendment”) is effective as of November 13, 2007 (the “Effective Date”).

     2. Amendments to Exercise Price Per Share.

	 	(a)	 	The exercise price of the options which vest January 1, 2005 or later,
to purchase 21,876 shares of Company common stock under grant number 32125 is
hereby increased to $16.75 per share; and
	 
	 	(b)	 	The exercise price of the options which vest January 1, 2005 or later,
to purchase 5,002 shares of Company common stock under grant number 31443 is hereby
increased to $15.26 per share.

     3. Extension of Exercisability Period. The options granted under the Agreements shall
remain exercisable until the date that is 90 days after the Company first becomes no longer subject
to a blackout with respect to its stock after the Effective Date of this Agreement; provided,
however, that in no event shall such options be exercisable beyond the earlier of: (a) 10 years
from the option’s date of grant, (b) the original expiration of the option’s term, or (c) December
31, 2008.

     4. Option Agreements. To the extent not expressly amended hereby, the Agreements
remain in full force and effect.

     5. Entire Agreement. This Amendment, taken together with the Agreements (to the extent
not expressly amended hereby), and any duly authorized written or electronic agreement entered into
by and between the Company and Optionee relating to the stock option grants evidenced by the
Agreements, represent the entire agreement of the parties, supersede any and all previous
contracts, arrangements or understandings between the parties with respect to the stock option
grants evidenced by the Agreements, and may be amended at any time only by mutual written agreement
of the parties hereto.

     This Amendment must be properly completed and signed by you and delivered to Stephen R.
Thompkins at McAfee, Inc., 5000 Headquarters Drive, Plano, Texas, 75024.

 

 

     IN WITNESS WHEREOF, this instrument is effective as of the Effective Date.

	 	 	 	 	 
	McAFEE, INC.

	 	OPTIONEE
	 	 
	 
	 	 	 	 
	/s/ Stephen R. Thompkins

	 	/s/ William Kerrigan	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	Signature

	 	Signature	 	 
	 
	 	 	 	 
	Stephen R. Thompkins

	 	William Kerrigan	 	 
	Vice President & Deputy General Counsel
	 	 	 	 
	 
	 	 	 	 
	 

	 	Signed:
November 19,
2007	 	 
	 

	 	 	 	 

-2-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00137-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00137-of-00352.parquet"}]]